EN


National Institute for Biological Standards and Control (NIBSC), 英国国家标准局,是WHO指定的国际标准品供应商,提供WHO超过90%的国际参考物质,用于体外诊断试剂,药物,疫苗等领域。


NIBSC国际参考物质
--更新日期 2024.5.20
Product code Product Description Category Sub-Category
234 IPV ELISA MAbs Type 1, 2 and 3  (Type 1; No: 234) Vaccines Yellow Fever
1050 IPV ELISA MAbs Type 1, 2 and 3 (Type 2; No: 1050) Diagnostics Immunoglobulins and Immune Sera
100976 pCAGGS-SARS-CoV-2-Spike Diagnostics Immunoglobulins and Immune Sera
100976 pCAGGS-SARS-CoV-2-Spike Diagnostics Immunoglobulins and Immune Sera
100978 VeroE6/TMPRSS2 Diagnostics Blood Transfusion and Transplantation
100978 VeroE6/TMPRSS2 Diagnostics Blood Transfusion and Transplantation
100980 SARS-CoV-2 infectious virus (BetaCoV/Australia/VIC01/2020 Diagnostics Blood Transfusion and Transplantation
100980 SARS-CoV-2 infectious virus (BetaCoV/Australia/VIC01/2020 Vaccines Clostridium
100985 pCAGGS_SARS-CoV-2_Spike D614G Vaccines Enteric disease
100985 pCAGGS_SARS-CoV-2_Spike D614G Vaccines Enteric disease
100986 pCAGGS-SARS-CoV-2-Spike Bristol Deletion Vaccines Tetanus
100986 pCAGGS-SARS-CoV-2-Spike Bristol Deletion Diagnostics Immunoglobulins and Immune Sera
100987 Inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020 Diagnostics Immunoglobulins and Immune Sera
100987 Inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020 Vaccines Diphtheria
100988 Nucleic acid extracts from inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020 Vaccines Staphylococcal Immune Sera
100988 Nucleic acid extracts from inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020 Diagnostics Haemostasis
100989 pCRII-SARS-CoV-2 (5'UTR-NSP2) Biotherapeutics Cell Reference Material
100989 pCRII-SARS-CoV-2 (5'UTR-NSP2) Vaccines Staphylococcal Immune Sera
100991 pCRII-SARS-CoV-2 (NSP4-NSP8) Diagnostics Livestock diseases
100991 pCRII-SARS-CoV-2 (NSP4-NSP8) Diagnostics Livestock diseases
100992 pCRII-SARS-CoV-2 (NSP4-NSP8) Vaccines Vaccinia
100992 pCRII-SARS-CoV-2 (NSP4-NSP8) Diagnostics Livestock diseases
100994 pCRII-SARS-CoV-2 (NSP15-NSP16) Diagnostics Livestock diseases
100994 pCRII-SARS-CoV-2 (NSP15-NSP16) Vaccines MMR
100996 pCRII-SARS-CoV-2 (ORF3a-ORF6) Biotherapeutics Haemostasis
100996 pCRII-SARS-CoV-2 (ORF3a-ORF6) Biotherapeutics Haemostasis
100998 SARS-CoV-2 infectious virus (CVR-GLA 1) Biotherapeutics Haemostasis
100998 SARS-CoV-2 infectious virus (CVR-GLA 1) Biotherapeutics Haemostasis
100999 SARS-CoV-2 infectious virus(CVR-GLA 2) Diagnostics Livestock diseases
100999 SARS-CoV-2 infectious virus(CVR-GLA 2) Vaccines Pertussis
101000 SARS-CoV-2 infectious virus(CVR-GLA 3) Vaccines Tuberculosis (V)
101000 SARS-CoV-2 infectious virus(CVR-GLA 3) Vaccines Tuberculosis (V)
101001 VeroE6-ACE2 Vaccines Clostridium
101001 VeroE6-ACE2 Vaccines Clostridium
101003 VeroE6-ACE2-TMPRSS2 Vaccines Livestock diseases
101003 VeroE6-ACE2-TMPRSS2 Diagnostics Livestock diseases
101004 A549-ACE2-TMPRSS2 Diagnostics Livestock diseases
101004 A549-ACE2-TMPRSS2 Biotherapeutics Mouse Embryonic Fibroblasts
101005 A549-ACE2 Clone8 Vaccines Pertussis
101005 A549-ACE2 Clone8 Vaccines Pertussis
101006 A549-ACE-2 Clone 8-TMPRSS2 Vaccines Pertussis
101006 A549-ACE-2 Clone 8-TMPRSS2 Vaccines Pertussis
101007 SARS-CoV-2 Trimeric Spike 50ug (1mg/ml in PBS) Sterile #28.05.2020 Vaccines Haemophilus Influenzae type b (Hib)
101007 SARS-CoV-2 Trimeric Spike 50ug (1mg/ml in PBS) Sterile #28.05.2020 Vaccines Pertussis
101008 HEK293T-ACE2-TMPRSS2 Vaccines Pertussis
101008 HEK293T-ACE2-TMPRSS2 Diagnostics Anti-Toxins
101009 Anti-SARS-CoV-2 Nucleocaspid protein (CR3009) Vaccines Diphtheria
101009 Anti-SARS-CoV-2 Nucleocaspid protein (CR3009) Vaccines Diphtheria
101010 Anti-SARS-CoV-2 Nucleocapsid protein (CR3018) Vaccines Clostridium
101010 Anti-SARS-CoV-2 Nucleocapsid protein (CR3018) Vaccines Clostridium
101019 VOC-202012/01 (B.1.1.7 lineage) lot 26012021 Vaccines Clostridium
101019 VOC-202012/01 (B.1.1.7 lineage) lot 26012021 Diagnostics Livestock diseases
101022 SARS-CoV-2 VOC202012/02 (B.1.351 lineage) passage 4 Diagnostics Anti-Toxins
101022 SARS-CoV-2 VOC202012/02 (B.1.351 lineage) passage 4 Diagnostics Livestock diseases
101023 pl.18SARS-CoV-2-Spike (B.1.1.7) 1ug (100ng/ul) lot #24032021 Vaccines Botulinum
101023 pl.18SARS-CoV-2-Spike (B.1.1.7) 1ug (100ng/ul) lot #24032021 Diagnostics Protein Hormones and Endocrine Products
101024 pl. 18SARS-CoV-2-Spike (B.1.351) 1ug (100ng/ul) lot #24032021 Diagnostics Blood Transfusion and Transplantation
101024 pl. 18SARS-CoV-2-Spike (B.1.351) 1ug (100ng/ul) lot #24032021 Vaccines Influenza
101025 4% formaldehyde inactivated SARS CoV-2 BetaCoV/Australia/VIC01/2020 from VeroE6/TMPRSS2 Vaccines Influenza
101025 4% formaldehyde inactivated SARS CoV-2 BetaCoV/Australia/VIC01/2020 from VeroE6/TMPRSS2 Diagnostics Blood Borne Pathogens
101027 Acid/heat inactivated SARS-CoV-2 (B.1.1.7) lot 17022021 Diagnostics Protein Hormones and Endocrine Products
101027 Acid/heat inactivated SARS-CoV-2 (B.1.1.7) lot 17022021 Diagnostics Blood Borne Pathogens
101029 SARS-CoV-2 Alpha (B.1.1.7) Purified RNA extracts lot 20052021 Diagnostics Blood Borne Pathogens
101029 SARS-CoV-2 Alpha (B.1.1.7) Purified RNA extracts lot 20052021 Diagnostics Protein Hormones and Endocrine Products
101030 SARS-CoV-2 VOC-202104/02 (B.1.617.2 lineage) Vaccines Meningococcal Reagents
101030 SARS-CoV-2 VOC-202104/02 (B.1.617.2 lineage) Diagnostics Protein Hormones and Endocrine Products
101031 SARS-CoV-2 VOC-21FEB02 (B.1.1.7 lineage  + E484K) Diagnostics Protein Hormones and Endocrine Products
101031 SARS-CoV-2 VOC-21FEB02 (B.1.1.7 lineage  + E484K) Diagnostics Blood Borne Pathogens
101032 SARS-CoV-2 Kappa (B.1.617.1 lineage Diagnostics Blood Transfusion and Transplantation
101032 SARS-CoV-2 Kappa (B.1.617.1 lineage Diagnostics Protein Hormones and Endocrine Products
101033 SARS-CoV-2 Delta (AY.1 sub-lineage) Diagnostics Protein Hormones and Endocrine Products
101033 SARS-CoV-2 Delta (AY.1 sub-lineage) Vaccines Influenza
101034 SARS-CoV-2 Mu (B.1.621 lineage) Vaccines Yellow Fever
101034 SARS-CoV-2 Mu (B.1.621 lineage) Vaccines Influenza
101035 Acid/Heat Inactivated SARS-CoV-2 Beta (B.1.351 lineage) Vaccines Influenza
101035 Acid/Heat Inactivated SARS-CoV-2 Beta (B.1.351 lineage) Vaccines Pertussis
101036 Acid/Heat Inactivated SARS-CoV-2 Delta (B.1.617.2 lineage Vaccines Pertussis
101036 Acid/Heat Inactivated SARS-CoV-2 Delta (B.1.617.2 lineage Vaccines Pertussis
101038 0.01% Formaldehyde Inactivated SARS-CoV-2 Beta (B.1.351 lineage) Vaccines Pertussis
101038 0.01% Formaldehyde Inactivated SARS-CoV-2 Beta (B.1.351 lineage) Vaccines Pertussis
101039 0.01% Formaldehyde Inactivated SARS-CoV-2 Delta (B.1.617.2 lineage) Vaccines Pertussis
101039 0.01% Formaldehyde Inactivated SARS-CoV-2 Delta (B.1.617.2 lineage) Vaccines Pertussis
101042 SARS-CoV-2 Nucleocapsid protein (His tagged) Vaccines Pertussis
101042 SARS-CoV-2 Nucleocapsid protein (His tagged) Vaccines Pertussis
101043 SARS-CoV-2 Nucleocapsid protein 203/204:RG>KR (His tagged) Vaccines Pertussis
101043 SARS-CoV-2 Nucleocapsid protein 203/204:RG>KR (His tagged) Vaccines Pertussis
101044 SARS-CoV-2 Omicron (lineage B.1.1.529) Vaccines Pertussis
101044 SARS-CoV-2 Omicron (lineage B.1.1.529) Vaccines Pertussis
101047 Inactivated (Acetic Acid + Heat)SARS-CoV-2 Omicron (BA.1 sublineage) Vaccines Pertussis
101047 Inactivated (Acetic Acid + Heat)SARS-CoV-2 Omicron (BA.1 sublineage) Vaccines Pertussis
101054 SARS-CoV-2 Omicron BA.1.1 sublineage lot 28032022 Vaccines Pertussis
101054 SARS-CoV-2 Omicron BA.1.1 sublineage lot 28032022 Vaccines Pertussis
101055 SARS-CoV-2 Omicron (BA.2) Vaccines Pertussis
101055 SARS-CoV-2 Omicron (BA.2) Vaccines Pertussis
101062 HEK293T-ACE2-30F-PLP2 Vaccines Pertussis
101062 HEK293T-ACE2-30F-PLP2 Vaccines Pertussis
00/410 MAPREC assay of poliovirus type 1 (Sabin).100% 480-A, 525-C DNA(1st International Reference Preparation) Vaccines Pertussis
00/416 Low Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation) Vaccines Pertussis
00/418 MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard) Vaccines Pertussis
00/418 MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard) Vaccines Pertussis
00/422 High Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation) Vaccines Pertussis
00/440 Influenza Antiserum A/Singapore/1/57 (H2) Vaccines Pertussis
00/440 Influenza Antiserum A/Singapore/1/57 (H2) Vaccines Pertussis
00/442 Influenza anti B/Yamanashi/166/98 Serum Vaccines Pertussis
00/498 Diphtheria Antitoxin Human IgG Vaccines Pertussis
00/500 Botulinum Type A-E Antitoxin, Human Serum Vaccines Pertussis
00/542 Influenza anti- A/Chick/Scotland/59 (H5N1) Serum Vaccines Pertussis
00/546 Influenza Antigen B/Johannesburg/5/99 Vaccines Pertussis
00/548 Influenza Antigen A/Singapore/1/57 (H2N2) Vaccines Pertussis
00/552 Influenza Antigen A/Duck/Singapore-Q/F119-3/97 (H5N3) Vaccines Pertussis
00/556 Influenza anti-B/Johannesburg/5/99/ Serum Vaccines Influenza
00/572 Interferon Beta (Human, rDNA, Glycosylated) (3rd International standard) Vaccines Influenza
00/574 Interferon Beta SER17 Mutein (Human, rDNA derived) Vaccines Influenza
00/576 Interferon Beta (Human, Fibroblast-derived, Glycosylated) Vaccines Influenza
007SP Human Anti-Pneumococcal capsule Reference Serum (1st International Standard) Biotherapeutics Cytokines and Growth Factors
01/412 Anti-Meningococcal Immunotype L3,7,9 Monoclonal Antibody Biotherapeutics Haemostasis
01/420 Interleukin-17 (Human rDNA derived)(WHO Reference Reagent) Diagnostics Haematinics and Haemoglobin
01/450 Influenza anti B/Guangdong/120/2000 Serum Vaccines Diphtheria
01/452 Influenza anti A/Panama/2007/99 (H3N2) HA serum Vaccines Influenza
01/506 Botulinum type F antitoxin, equine Vaccines Influenza
01/508 Botulinum type C antitoxin, equine Vaccines Influenza
01/510 Botulinum Antitoxin Equine Type D Vaccines Influenza
01/512 Botulinum type G antitoxin, equine Vaccines Polio
01/514 Anti-Meningococcal Serosubtype P1.7 Monoclonal Antibody Biotherapeutics Protein Hormones and Endocrine Products
01/538 Anti-Meningococcal  Serosubtype P1.16 mAb Diagnostics Protein Hormones and Endocrine Products
01/546 Influenza Antigen B/Guangdong/120/2000 Diagnostics Protein Hormones and Endocrine Products
01/600 Anti-Toxoplasma IgG, Human(International Standard) Biotherapeutics Protein Hormones and Endocrine Products
01/602 Anti-Parvovirus B19, plasma, human(2nd International Standard) Vaccines Diphtheria
01/612 Influenza Virus infectious B/Hawaii/10/01 Vaccines Influenza
01/614 Influenza Antigen A/New Caledonia/20/99 Biotherapeutics Blood Transfusion and Transplantation
02/102 Influenza anti A/Panama/2007/99 Serum Vaccines Polio
02/144 Anti-Meningococcal Serosubtype P1.15 mAb Vaccines Influenza
02/148 Anti-Meningococcal Serosubtype P1.4 mAb Vaccines Polio
02/178 Anti-Meningococcal Serosubtype P1.2 mAb Vaccines Polio
02/180 Anti-Meningococcal Serotype P2.2a mAb Vaccines Influenza
02/182 Anti-Japanese Encephalitis Virus Plasma, Human Vaccines Influenza
02/184 Anti-Japanese Encephalitis (Anti-JE) Virus Negative Control Plasma, Human Diagnostics Protein Hormones and Endocrine Products
02/210 HIV (antibody), 1st International Reference Panel Vaccines Influenza
02/226 IVIG negative control for use with IVIG + anti-D(WHO Reference Reagent) Vaccines MMR
02/228 IVIG + anti-D for use with negative control IVIG(WHO Reference Reagent) Vaccines Hepatitis A Virus
02/230 Biotinylated Brad-5 (Bio-Brad-5) Vaccines Pertussis
02/232 Tetanus Toxoid (Non-Adsorbed) Biotherapeutics Cytokines and Growth Factors
02/294 Influenza Antiserum A/chick/Italy/1347/99 (H7N1) Vaccines Influenza
02/308 Anti-Meningococcal Serotype P3.4 mAb Vaccines Influenza
02/310 Anti-Meningococcal Serotype P3.15 mAb Vaccines Influenza
02/318 Botulinum Antitoxin Equine Type E Biotherapeutics Cytokines and Growth Factors
02/320 Anti-Meningococcal Serosubtype P1.3 mAb Vaccines Influenza
02/336 Influenza Antigen A/New Caledonia/20/99 Biotherapeutics Cytokines and Growth Factors
02/338 Influenza anti A/Panama/2007/99 Serum Vaccines Influenza
02/342 Protein C Plasma, Human(2nd International Standard) Vaccines Pertussis
03/104 HTLV-1 (antibody) Monitor Sample Vaccines Pertussis
03/110 Influenza anti B/Shangdong/9/97 Serum Vaccines Pertussis
03/110 Influenza anti B/Shangdong/9/97 Serum Biotherapeutics Haemostasis
03/114 Anti-Meningococcal Serosubtype P1.1 mAb Vaccines Pertussis
03/124 Thrombopoietin ( Human rDNA derived) Diagnostics Protein Hormones and Endocrine Products
03/142 Anti-Meningococcal Serosubtype P1.14 mAb Biotherapeutics Cytokines and Growth Factors
03/148 Keratinocyte growth factor (KGF, FGF-7)(24-163)(1st WHO Reference Reagent) Vaccines Influenza
03/150 Keratinocyte Growth Factor (KGF,FGF-7)(1st WHO Reference Reagent) Vaccines Influenza
03/152 Anti-HPA-1a (International Standard) Vaccines Influenza
03/164 Anti-B minimum potency reference preparation(International Standard) Biotherapeutics Protein Hormones and Endocrine Products
03/178 Vitamin B12, Serum Folate and holoTC (International standard) Biotherapeutics Protein Hormones and Endocrine Products
03/182 Anti-Meningococcal Serotype P3.21 mAb Vaccines Polio
03/188 Anti-A minimum potency reference preparation(International Standard) Vaccines Polio
03/190 Anti-HPA-3a(minimum potency)(WHO Reference Reagent) Biotherapeutics Cytokines and Growth Factors
03/192 Thyroid-Stimulating Hormone, Recombinant, Human, for Bioassay (1st International standard) Biotherapeutics Cytokines and Growth Factors
03/200 Interleukin - 18 (Human rDNA derived)(WHO Reference Reagent) Biotherapeutics Protein Hormones and Endocrine Products
03/210 Anti-Meningiococcal Serosubtype P1.6 mAb Biotherapeutics Cytokines and Growth Factors
03/212 Influenza anti A/Wyoming/03/03 Serum Biotherapeutics Cytokines and Growth Factors
03/220 Influenza Antigen A/Wyoming/03/03 Biotherapeutics Cytokines and Growth Factors
03/224 Anti-Meningococcal Serosubtype P1.10 mAb Vaccines Meningococcal Reagents
03/226 Anti-Meningococcal Serosubtype P1.5 mAb Vaccines Meningococcal Reagents
03/228 Protein S, Plasma, Human(2nd International Standard) Biotherapeutics Haemostasis
03/236 Anti-Meningococcal Serosubtype P1.13 mAb Biotherapeutics Cytokines and Growth Factors
03/242 Influenza anti A/Puerto Rico/8/34 (H1N1) HA Serum Biotherapeutics Cytokines and Growth Factors
03/244 Influenza Antiserum A/chick/Germany/N/49 Diagnostics Protein Hormones and Endocrine Products
03/258 Influenza Antigen A/New Caledonia/20/99 (IVR-116) Biotherapeutics Cytokines and Growth Factors
03/262 Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel) Biotherapeutics Cytokines and Growth Factors
04/122 Anti-Meningococcal Serosubtype P1.12 mAb Biotherapeutics Cytokines and Growth Factors
04/160 Influenza Virus infectious NYMC X-147 Biotherapeutics Cytokines and Growth Factors
04/166 TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived(1st WHO Reference Reagent) Biotherapeutics Haemostasis
04/170 Influenza Virus infectious A/Wellington/1/2004 Biotherapeutics Cytokines and Growth Factors
04/172 Influenza Virus infectious IVR-139 Biotherapeutics Cytokines and Growth Factors
04/176 Plasmodium falciparum DNA for NAT Assays(1st International Standard) Vaccines Polio
04/198 Anti-Meningococcal Serotype P3.1 mAb Diagnostics Haematinics and Haemoglobin
04/202 Influenza Antigen B/ Jiangsu/10/2003 Vaccines Influenza
04/224 Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004 Diagnostics Blood Borne Pathogens
04/228 Influenza anti B/ Neuraminidase Serum Vaccines Influenza
04/242 Influenza anti B/Jiangsu/10/2003 HA Serum Vaccines Influenza
04/246 Anti-Meningococcal Serogroup W-135 mAb Vaccines Polio
04/248 Anti-Meningococcal Serosubtype P1.19 mAb Biotherapeutics Cytokines and Growth Factors
04/252 Protein C Concentrate, Human(1st International Standard) Biotherapeutics Cytokines and Growth Factors
04/260 Influenza anti A/New Caledonia/20/99 HA Serum Vaccines Influenza
04/262 Influenza anti A/New York/55/2004 HA Serum Vaccines Influenza
04/264 Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157) Biotherapeutics Cytokines and Growth Factors
05/102 Influenza Virus infectious NYMC BX-7 Biotherapeutics Haemostasis
05/106 Anti-HPA-1a minimum potency reagent(2nd WHO Reference reagent) Biotherapeutics Cytokines and Growth Factors
05/112 Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard). Biotherapeutics Haemostasis
05/130 Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005) Biotherapeutics Cytokines and Growth Factors
05/134 Anti-human papillomavirus type 16 serum (1st International Standard) Diagnostics Protein Hormones and Endocrine Products
05/162 Alpha-1-Antitrypsin, plasma derived(1st International standard) Biotherapeutics Cytokines and Growth Factors
05/190 Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody Vaccines Pertussis
05/192 Anti Meningococcal Serotype P2.2b Monoclonal Antibody Vaccines Influenza
05/234 Influenza Antigen A/Hiroshima/52/2005 (H3N2) (IVR-142) Vaccines Influenza
05/236 Influenza anti A/Wisconsin/67/2005 Serum Vaccines Influenza
05/252 Influenza anti B Neuraminidase Serum Vaccines Influenza
06/108 Influenza Virus infectious IVR-116 Vaccines Influenza
06/124 Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 2 (1st International Standard) Biotherapeutics Cytokines and Growth Factors
06/128 Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 3 (1st International Standard) Biotherapeutics Cytokines and Growth Factors
06/140 Pertussis Antiserum(human)1st IS-WHO international Standard. Biotherapeutics Cytokines and Growth Factors
06/142 Pertussis Antiserum (Human) 1st WHO Reference Reagent Vaccines Influenza
06/164 Influenza Virus infectious 1 VR-142 Biotherapeutics Cytokines and Growth Factors
06/166 Antithrombin Concentrate, Human (3rd International Standard) Biotherapeutics Cytokines and Growth Factors
06/170 Influenza Antigen A/New Caledonia/20/99 Biotherapeutics Cytokines and Growth Factors
06/192 Influenza anti A/turkey/Turkey/1/05 (NIBRG-23)  HA serum(sheepSH465 & SH466) Vaccines Influenza
06/202 Human Papillomavirus (HPV) Type 16 DNA (1st International Standard) Biotherapeutics Cytokines and Growth Factors
06/206 Human Papillomavirus (HPV) Type 18 DNA (1st International Standard) Biotherapeutics Cytokines and Growth Factors
06/242 Influenza Virus Infectious NYMC X-161B (A/Wisconsin/67/2005 HGR) Biotherapeutics Cytokines and Growth Factors
0688 SARS CoV-1 spike S1 protein Diagnostics Protein Hormones and Endocrine Products
0688 SARS CoV-1 spike S1 protein Biotherapeutics Cytokines and Growth Factors
07/102 Influenza Antigen A/Solomon Islands/3/2006 (H1N1)(IVR-145) Vaccines Influenza
07/104 Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum Vaccines Influenza
07/112 Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23 Vaccines Influenza
07/144 Influenza Virus infectious IVR-145, Vaccines Influenza
07/146 Influenza anti A/HongKong/1073/99 like (H9) HA Serum (sheep) Biotherapeutics Cytokines and Growth Factors
07/148 Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum Biotherapeutics Cytokines and Growth Factors
07/150 Human Plasma Anti-Influenza H5N1 (1st International Standard) Vaccines Influenza
07/164 Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard) Vaccines Influenza
07/184 Influenza anti B/Malaysia/2506/2004-HA Serum Diagnostics Haematinics and Haemoglobin
07/202 Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent) Biotherapeutics Haemostasis
07/216 Diphtheria Toxoid (Adsorbed) (4th International Standard) Vaccines MMR
07/222 RhD/SRY Plasma DNA sensitivity standard (1st WHO Reference Reagent) Biotherapeutics Cytokines and Growth Factors
07/228 Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard” Vaccines Influenza
07/270 BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent) Vaccines Influenza
07/272 BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent) Vaccines Influenza
07/274 BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent) Vaccines Influenza
07/278 Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum       (NIBRG-60) (sheep SH474 AND SH475) Biotherapeutics Cytokines and Growth Factors
07/286 Monitor sample for HBsAg 0.05IU/ml Biotherapeutics Cytokines and Growth Factors
07/288 Hepatitis B Surface Antigen (HBsAg) British Working Standard 0.2 IU/ml Biotherapeutics Protein Hormones and Endocrine Products
07/290 Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6 Biotherapeutics Protein Hormones and Endocrine Products
07/298 Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques Vaccines MMR
07/306 Anti-A and anti-B in IVIG: Positive control for haemagglutination tests (WHO Reference Reagent) Biotherapeutics Cytokines and Growth Factors
07/316 Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.) Biotherapeutics Cytokines and Growth Factors
07/318 Meningococcal Group C Polysaccharide Vaccines Influenza
07/328 Unfractionated Heparin (6th I.S.) Biotherapeutics Cytokines and Growth Factors
07/336 Influenza Antigen A/mallard/Netherlands/12/00(H7N3) NIBRG-60 Biotherapeutics Cytokines and Growth Factors
07/338 Influenza antiserum A/Anhui/1/05 (H5) Biotherapeutics Cytokines and Growth Factors
07/348 Influenza Virus infectious NYMC X-171B Biotherapeutics Protein Hormones and Endocrine Products
07/350 Blood Coagulation Factor VIII Concentrate (8th I.S.) Biotherapeutics Protein Hormones and Endocrine Products
07/358 Influenza Virus infectious NIB-50 Vaccines Influenza
07/362 Influenza Virus infectious IVR-149 Biotherapeutics Protein Hormones and Endocrine Products
08/100 Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1) Biotherapeutics Cytokines and Growth Factors
08/108 Influenza Virus Infectious NIBRG-91 (H9N2) Biotherapeutics Cytokines and Growth Factors
08/126 Influenza Anti N1 Neuraminidase Serum SH485 Biotherapeutics Cytokines and Growth Factors
08/138 Influenza Virus Infectious B/Florida/4/2006 Vaccines Influenza
08/140 Influenza Antigen B/Florida/4/2006 Biotherapeutics Cytokines and Growth Factors
08/142 Influenza antiserum A/Anhui/1/05 (H5) Biotherapeutics Cytokines and Growth Factors
08/154 Influenza Virus Infectious NIBRG-12 (H5N1) Diagnostics Immunoglobulins and Immune Sera
08/156 Influenza Virus Infectious NIBRG-23 30060  VE3 (H5N1) Diagnostics Blood Borne Pathogens
08/158 Fragile X Syndrome gDNA (1st International Genetic Reference Panel) Biotherapeutics Cytokines and Growth Factors
08/160 Haemophilia A, Intron-22 inversion, gDNA,  (1st International Genetic Reference Panel) Vaccines MMR
08/178 Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques Biotherapeutics Cytokines and Growth Factors
08/184 Influenza Antigen B/Malaysia/2506/2004 Vaccines Pertussis
08/202 Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1) Vaccines Influenza
08/204 Thyroid Stimulating Antibody (2nd I.S.) Vaccines Influenza
08/208 Influenza Antigen A/HongKong/1073/99 (H9N2) Vaccines Influenza
08/210 Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86) Vaccines Tetanus
08/216 Influenza Antigen A/Cambodia/RO405050/2007 (H5N1) Vaccines Pertussis
08/218 Tetanus Toxoid Adsorbed (4th International Standard) Diagnostics Haematinics and Haemoglobin
08/228 Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91 Biotherapeutics Protein Hormones and Endocrine Products
08/230 Streptodornase (2nd International Standard) Vaccines Pertussis
08/246 Influenza anti A/Brisbane/10/2007- like HA serum Vaccines Pertussis
08/248 Influenza Virus Infectious NIBRG-107 VE2 30480 Vaccines Pertussis
08/250 Influenza Virus Infectious NIBRG-63 VE2  30500 (H7N1) Vaccines Pertussis
08/252 Influenza Virus Infectious  NIBRG-109  VE2  30490 Vaccines Influenza
08/256 C1- Inhibitor, Concentrate (1st International Standard) Biotherapeutics Protein Hormones and Endocrine Products
08/258 Antithrombin, Plasma (3rd International Standard) Vaccines Pertussis
08/262 C1 Inhibitor (Plasma)(1st International Standard) Biotherapeutics Cytokines and Growth Factors
08/266 Sex Hormone Binding Globulin.(2nd International Standard) Biotherapeutics Cytokines and Growth Factors
08/268 Influenza Antigen A/mallard/England/727/2006 (H2N3)NIBRG-107 Biotherapeutics Cytokines and Growth Factors
08/278 Influenza Antigen A/Brisbane/10/2007-like (Prepared from A/Uruguay/716/2007 (NYMC X-175C)) Biotherapeutics Cytokines and Growth Factors
08/298 Influenza Virus Infectious B/Brisbane/33/2008  30720   E5 Biotherapeutics Cytokines and Growth Factors
08/300 Influenza Virus infectious IVR-148 Vaccines Influenza
08/304 Influenza virus infectious NYMC X-175C Vaccines Influenza
08/322 Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing Vaccines Influenza
08/324 Human Rhinovirus Genogroup A Working Reagent for Nucleic Acid Amplification Testing Biotherapeutics Cytokines and Growth Factors
08/356 Influenza antiserum A/Japan/305/57 (H2) Vaccines Influenza
08/362 Influenza Antigen A/New York/107/2003 (H7N2)NIBRG-109 Biotherapeutics Cytokines and Growth Factors
09/100 Influenza anti A/mallard/England/727/2006 (N3) NA serum (NIBRG-107) (Sheep SH503) Diagnostics Protein Hormones and Endocrine Products
09/110 Parvovirus B19 DNA Nucleic Acid Amplification Technology(NAT) based assays Genotype Panel(1st International Standard) Biotherapeutics Protein Hormones and Endocrine Products
09/130 Influenza Virus Infectious  NIBRG-122 Vaccines Influenza
09/136 Granulocyte Colony Stimulating Factor (Human, rDNA Derived)(2nd International Standard) Biotherapeutics Cytokines and Growth Factors
09/138 Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR  (1st I.S.) Vaccines Pertussis
09/140 Prader Willi & Angelman Syndromes, Human gDNA,(1st International Genetic Reference Panel) Vaccines Influenza
09/148 Influenza anti A/New York/107/2003 (H7) HA serum (Sheep SH504 and SH505) Vaccines Influenza
09/162 Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard) Diagnostics Haematinics and Haemoglobin
09/170 Anti-Meningococcal factor H binding protein variant 1 (JAR4) monoclonal antibody Diagnostics Haematinics and Haemoglobin
09/172 Blood coagulation Factors II, VII, IX, X Plasma (4th International Standard 2010) Biotherapeutics Cytokines and Growth Factors
09/174 Influenza Antigen A/California/7/09 (H1N1)v (NYMCX-179A)(Cell Derived) Biotherapeutics Cytokines and Growth Factors
09/182 VWF Factor Concentrate (2nd International Standard) Vaccines Influenza
09/184 Influenza Antigen A/Vietnam/1194/2004 (H5N1) NIBRG-14 Vaccines Influenza
09/186 Chagas (anti-Trypanosoma cruzi II) antibody in human plasma(1st International Standard) Vaccines Influenza
09/188 Chagas (anti-Trypanosoma cruzi I) antibody in Human Plasma (1st International Standard) Biotherapeutics Protein Hormones and Endocrine Products
09/196 Influenza Antigen A/California/7/09 (H1N1)v (NIBRG-121xp) (Egg Derived) Biotherapeutics Cytokines and Growth Factors
09/222 Human anti-Haemophilus influenzae b reference serum Biotherapeutics Cytokines and Growth Factors
09/234 Transforming Growth Factor-BETA 3 (Human, rDNA derived TGF-ß 3) (1st International Standard) Biotherapeutics Cytokines and Growth Factors
09/236 Influenza Virus Infectious IVR-153 Vaccines Influenza
09/242 Fibrinogen Concentrate (B)(2nd International Standard) Vaccines Influenza
09/260 Epstein-Barr Virus for Nucleic Acid Amplification Techniques(1st International Standard) Vaccines Influenza
09/264 Fibrinogen Plasma (D)(3rd International Standard) Vaccines Influenza
09/266 GLIAL CELL-DERIVED NEUROTROPHIC FACTOR (GDNF), human, rDNA-derived Biotherapeutics Cytokines and Growth Factors
09/268 Influenza Virus Infectious NIBRG-121xp Biotherapeutics Protein Hormones and Endocrine Products
09/272 Placental growth factor Ala 21 - Arg 149, human, rDNA-derived (PlGF, PlGF-1) Biotherapeutics Protein Hormones and Endocrine Products
09/274 Influenza Virus Infectious  NYMC X-185 Biotherapeutics Cytokines and Growth Factors
09/280 Influenza Virus Infectious NIB-64 Biotherapeutics Protein Hormones and Endocrine Products
09/284 Anti-Human Neutrophil Antibody 1a WHO Reference Reagent Diagnostics Haematinics and Haemoglobin
09/296 Pro-Insulin, human (1st International Standard) Diagnostics Immunoglobulins and Immune Sera
09/304 Influenza Virus Infectious IVR-155 Diagnostics Protein Hormones and Endocrine Products
09/308 Influenza Serology Antigen Reagent X-179A (H1N1pdm) for HI Assay Vaccines Influenza
09/310 Influenza Antigen A/Wisconsin/15/09 (H3N2) (NYMCX-183) Vaccines Influenza
10/104 Reteplase Reference Material Biotherapeutics Protein Hormones and Endocrine Products
10/120 Influenza Anti A/Brisbane/59/2007 (IVR 148)(H1N1) HA serum Diagnostics Allergen
10/128 Diphtheria Polyclonal Antibody Vaccines Influenza
10/130 Diphtheria Monoclonal Antibody Vaccines Influenza
10/132 Tetanus Polyclonal Antibody Vaccines Influenza
10/134 Tetanus Monoclonal Antibody Diagnostics Blood Transfusion and Transplantation
10/140 Anti-human papillomavirus[HPV] 18 serum (1st International Standard) Biotherapeutics Protein Hormones and Endocrine Products
10/142 Anti-human leukocyte antigen antibodies (negative plasma) Diagnostics Allergen
10/164 Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain]. Vaccines Influenza
10/164 Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain]. Vaccines Influenza
10/168 Oral Poliovaccine Sabin Type 3 reference Diagnostics Protein Hormones and Endocrine Products
10/168 Oral Poliovaccine Sabin Type 3 reference Diagnostics Allergen
10/176 Interleukin-29 (Interferon Lambda, Human, rDNA derived) WHO Reference Reagent Diagnostics Protein Hormones and Endocrine Products
10/178 Endotoxin (3rd International Standard) Biotherapeutics Protein Hormones and Endocrine Products
10/198 Anti-malaria (Plasmodium falciparum) human serum(1st WHO Reference Reagent) Diagnostics Protein Hormones and Endocrine Products
10/202 Influenza antibody (Human) to A/California/7/2009 'like' (H1N1v) virus (2nd International Standard) Vaccines Influenza
10/214 Influenza Anti N2 Neuraminidase Serum SH395 & SH396 Vaccines Influenza
10/218 Influenza Anti A/California/7/2009 (N1) NA Serum Vaccines Influenza
10/226 Influenza Virus Infectious IVR-158 Biotherapeutics Protein Hormones and Endocrine Products
10/232 Blood Group Genotyping Reference Reagent RBC1 (OR1R2)(WHO Reference Reagent) Biotherapeutics Cytokines and Growth Factors
10/234 Blood Group Genotyping Reference Reagent RBC12 (ODpsi)(WHO Reference Reagent) Biotherapeutics Protein Hormones and Endocrine Products
10/236 Blood Group Genotyping Reference Reagent RBC4 (AR1R1)(WHO Reference Reagent) Biotherapeutics Haemostasis
10/238 Blood Group Genotyping Reference Reagent RBC5 (Brr)(WHO Reference Reagent) Biotherapeutics Haemostasis
10/242 Toxoplasma gondii DNA Nucleic Acid Amplification Techniques(1st International Standard) Diagnostics Haematinics and Haemoglobin
10/252 Factor VII Concentrate (2nd International Standard) Biotherapeutics Protein Hormones and Endocrine Products
10/258 Influenza Antigen A/California/7/2009-like(NIB-74) Biotherapeutics Cytokines and Growth Factors
10/262 Diphtheria Antitoxin Human IgG(1st International Standard) Vaccines Polio
10/272 BCG vaccine of Moreau-RJ sub-strain(1st WHO Reference Reagent) Diagnostics Allergen
10/286 Follicle Stimulating Hormone, Luteinizing Hormone human, urinary for bioassay(5th International Standard) Diagnostics Allergen
11/108 Influenza Virus infectious NYMC X-187 Biotherapeutics Protein Hormones and Endocrine Products
11/126 Factors II and X Concentrate (4th International standard) Biotherapeutics Protein Hormones and Endocrine Products
11/134 Influenza Antigen A/California/7/2009 (H1N1) Like (A/Brisbane/10/2010- cell derived) Diagnostics Protein Hormones and Endocrine Products
11/170 Erythropoietin, recombinant, for Bioassay (3rd International Standard) Biotherapeutics Protein Hormones and Endocrine Products
11/176 (3rd International Standard) Low Molecular Weight Heparin Vaccines Influenza
11/184 High Molecular Weight Urokinase(2nd International Standard) Vaccines Influenza
11/206 Influenza anti-A/Perth/16/2009 HA Serum Vaccines Influenza
11/206 Influenza anti-A/Perth/16/2009 HA Serum Vaccines Influenza
11/210 Anti-human CD4 FITC conjugated 0.5ml Biotherapeutics Protein Hormones and Endocrine Products
11/212 Biosynthetic Human Insulin (2nd WHO international Standard) Biotherapeutics Haemostasis
11/214 Blood Group Genotyping Reference Reagents Panel (WHO Reference Reagent) Vaccines Influenza
11/216 Chagas Antibody Reference Panel ( 1st International Standard) Vaccines Influenza
11/222 Influenza Virus Infectious NIB-79 Vaccines Influenza
11/232 Influenza Virus Infectious B/Texas/6/2011 Vaccines Influenza
11/234 Immunoglobulin E(IgE) human serum (3rd International Standard) Vaccines Influenza
11/242 Viral Multiplex Reference Diagnostics Protein Hormones and Endocrine Products
11/244 Influenza Virus Infectious NYMC BX-49 Diagnostics Allergen
12/100 Influenza Virus Infectious NYMC X-217 Diagnostics Allergen
12/104 International Standard for IPV 12/104 (3rd International Standard) Diagnostics Allergen
12/106 Influenza Antigen B/Hubei-Wujiagang/158/2009 (NYMCBX-39) Vaccines Influenza
12/110 Influenza Antigen B/Wisconsin/1/2010 (cell derived) Vaccines Influenza
12/112 Influenza Antigen A/Victoria/210/2009 (H3N2) (NYMCX-187) Biotherapeutics Protein Hormones and Endocrine Products
12/114 Influenza Antigen A/Victoria/361/2011 (H3N2) (IVR-165) Biotherapeutics Protein Hormones and Endocrine Products
12/116 Influenza anti-A/Victoria/361/2011-like HA serum Diagnostics Immunoglobulins and Immune Sera
12/118 Influenza anti-B/Wisconsin/1/2010-like HA serum Biotherapeutics Protein Hormones and Endocrine Products
12/122 Influenza virus infectious A/turkey/Italy/3889/1999 (H7N1) Diagnostics Allergen
12/154 Tumour Necrosis Factor alpha (human rDNA derived)(3rd International Standard) Diagnostics Allergen
12/188 Pegylated Granulocyte Colony Stimulating Factor (Human, rDNA derived) (1st International Standard) Diagnostics Allergen
12/198 Influenza virus infectious B/Wisconsin/1/2010 34490 E5 Biotherapeutics Protein Hormones and Endocrine Products
12/202 Influenza virus infectious  NYMC BX-39 Diagnostics Allergen
12/204 Influenza Virus Infectious IVR-165 Diagnostics Allergen
12/208 Parvovirus B19 (3rd International Standard) Diagnostics Immunoglobulins and Immune Sera
12/224 HIV-1  NAT subtypes (Main)(2nd International Reference Panel Preparation) Vaccines Influenza
12/226 HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard) Vaccines Influenza
12/244 Vi polysaccharide of C freundii  WHO 1st International Standard Biotherapeutics Protein Hormones and Endocrine Products
12/250 Influenza anti A/Mallard/England 727/2006 (H2) HA Serum Diagnostics Immunoglobulins and Immune Sera
12/252 ADAMTS 13 Plasma (1st International Standard) Biotherapeutics Protein Hormones and Endocrine Products
12/278 2nd Pneumococcal QC Serum Panel Vaccines Influenza
12/282 Diphtheria Toxin 1Lf/ml Diagnostics Immunoglobulins and Immune Sera
12/284 Anti-meningococcal serogroup Y monoclonal antibody Diagnostics Allergen
12/290 Influenza Virus Infectious B/Brisbane/36/2012 Diagnostics Protein Hormones and Endocrine Products
12/294 Influenza Virus Infectious NYMC BX-51C Biotherapeutics Haemostasis
12/300 Negative Control IVIG (for use with IVIG and Anti-D) Diagnostics Protein Hormones and Endocrine Products
12/306 Haemophilus Influenzae  Polysaccharide Polyribosyl Ribitol Phosphate (PRP)(2nd International Standard) Diagnostics Protein Hormones and Endocrine Products
13/100 Activated Blood Coagulation Factor XI (FXIa), Human  (1st International Standard) Diagnostics Protein Hormones and Endocrine Products
13/106 Influenza Antigen B/Massachusetts/02/2012 Diagnostics Protein Hormones and Endocrine Products
13/108 Anti-Meningococcal serogroup B monoclonal antibody Diagnostics Allergen
13/112 Influenza Antigen A/Texas/50/2012 (NYMC X-223) Biotherapeutics Haemostasis
13/116 Influenza Antigen A/Texas/50/2012 (NYMC X-223A) Diagnostics Miscellaneous
13/122 Erythropoietin Antibody Reference Panel Negative Control Antibody (1st WHO Reference Panel) Diagnostics Protein Hormones and Endocrine Products
13/126 Influenza anti-B/Brisbane/60/2008-like HA serum Vaccines Enteric disease
13/128 Influenza Virus Infectious NIBRG-269 Vaccines Enteric disease
13/132 Antibodies, Human, to Toxoplasma gondii (4th International Standard). Diagnostics Protein Hormones and Endocrine Products
13/134 Influenza Antigen B/Massachusetts/02/2012 (Egg derived) Diagnostics Blood Transfusion and Transplantation
13/146 C-Peptide, Human (1st International Standard). Vaccines Malaria
13/148 IVIG + anti-D for use with negative control IVIG Vaccines Malaria
13/152 Influenza Antigen B/Massachusetts/02/2012 (Cell Derived) Vaccines Malaria
13/162 Influenza Antigen A/Texas/50/2012 (NYMC X-223A) (Cell derived) Vaccines Malaria
13/164 Influenza Antigen A/California/7/2009 (H1N1pdm)(NYMC X-179A) Vaccines Malaria
13/166 Influenza anti-A/Anhui/1/2013 (N9) NA Serum Vaccines Malaria
13/168 Human Measles Mvi/Moscow Rus/1988 Genotype A Virus for Nucleic Acid Amplification Techniques Vaccines Malaria
13/172 Lupus Anticoagulant (1st International Reference Panel) Biotherapeutics Protein Hormones and Endocrine Products
13/176 Influenza Virus Infectious NIBRG-88 Vaccines Pertussis
13/178 Influenza Anti-A/Texas/50/2012-like HA serum Biotherapeutics Protein Hormones and Endocrine Products
13/182 Influenza Anti-B/Massachusetts/02/2012-like HA Serum Diagnostics Immunoglobulins and Immune Sera
13/200 Influenza Virus Infectious NIB-74 Biotherapeutics Protein Hormones and Endocrine Products
13/202 Influenza Virus infectious NIB-74xp Diagnostics Immunoglobulins and Immune Sera
13/204 TNF Rec II- FC Fusion protein (1st International Standard) Diagnostics Immunoglobulins and Immune Sera
13/206 Plasmin (4th International Standard) Diagnostics Immunoglobulins and Immune Sera
13/212 Diphtheria Toxoid for use in Flocculation Test (3rd International Standard) Diagnostics Immunoglobulins and Immune Sera
13/214 HIV-1 Circulating Recombinant Forms RNA (1st International Reference Panel) Diagnostics Immunoglobulins and Immune Sera
13/216 Anti-meningococcal factor H binding protein variant 1 (JAR5) monoclonal Vaccines Diphtheria
13/218 Polio Anti Sabin type 1 (inactivated) Serum Biotherapeutics Protein Hormones and Endocrine Products
13/218 Polio Anti Sabin type 1 (inactivated) Serum Diagnostics Protein Hormones and Endocrine Products
13/220 Polio Anti Sabin type 2 (inactivated) serum Biotherapeutics Protein Hormones and Endocrine Products
13/220 Polio Anti Sabin type 2 (inactivated) serum Diagnostics Protein Hormones and Endocrine Products
13/222 Polio Anti Sabin type 3 (inactivated) serum Diagnostics Quality Control Reagent (D)
13/222 Polio Anti Sabin type 3 (inactivated) serum Vaccines Clostridium
13/224 Influenza virus Infectious NIB-85. 36210  E5 Vaccines Clostridium
13/228 Influenza Virus Infectious. A/Almaty/2958/2013. 35790 E4 Biotherapeutics Immunoglobulins and Immune Sera
13/234 Influenza antigen B/Brisbane/60/08 Vaccines Clostridium
13/238 Anti-EV71 serum LOW (WHO Reference Reagent) Biotherapeutics Protein Hormones and Endocrine Products
13/240 Tetanus Immunoglobulin, Human (2nd WHO International Standard) Vaccines Tetanus
13/242 FEIBA Concentrate 2nd NIBSC Working Reference Standard Vaccines Botulinum
13/246 Meningococcal serogroup A polysaccharide (1st WHO International Standard). Vaccines Botulinum
13/248 Influenza virus infectious NIBRG-267 (H7N9) Biotherapeutics Protein Hormones and Endocrine Products
13/250 Influenza Virus Infectious NIBRG-268 (H7N9) Vaccines Clostridium
13/252 Influenza virus infectious NYMC X-223A Vaccines Pertussis
13/256 Influenza virus infectious. NYMC x-233 Vaccines Clostridium
13/258 Influenza virus infectious NYMC X-233A Vaccines Clostridium
13/262 Meningococcal serogroup A polysaccharide Diagnostics Livestock diseases
13/264 Influenza Virus Infectious NYMC X-223 Vaccines Influenza
14/100 Human Papillomavirus (HPV) 11 DNA (1st International Standard) Vaccines Influenza
14/104 Human Papillomavirus (HPV) Type 45 DNA (1st International Standard) Vaccines Influenza
14/106 Influenza virus infectious. NYMC BX-51B Vaccines Pertussis
14/114 JC Virus (JCV) DNA (1st International Standard) Vaccines Meningococcal Reagents
14/116 Influenza Virus Infectious NYMC X-179A Vaccines Influenza
14/118 Influenza virus infectious B/Massachusetts/2/2012 Vaccines Influenza
14/140 1st International Standard for Anti EV71 Serum Human Vaccines Influenza
14/144 Influenza anti-N2 Neuraminidase serum (A/Victoria/361/2011) Vaccines Influenza
14/146 Influenza Antigen B/Brisbane/60/2008 (NYMCBX-35)(Cell Derived) Vaccines Influenza
14/148 Human Blood Factor IX Concentrate (5th International Standard). Vaccines Influenza
14/156 Meningococcal group X polysaccharide (1st WHO International Standard) Vaccines Influenza
14/160 High titre anti-A in IVIG working reference reagent Vaccines Influenza
14/174 Botulinum Type A Antitoxin, Equine Vaccines Influenza
14/198 HBV,HCV,HIV Multiplex Vaccines Influenza
14/198 HBV,HCV,HIV Multiplex Vaccines Influenza
14/200 Influenza Antigen A/Puerto Rico/8/34 (HINI) Vaccines Meningococcal Reagents
14/206 Influenza virus infectious NYMC X-247 Vaccines Influenza
14/210 Biological activities of Rituximab WHO 1st International Standard Diagnostics Quality Control Reagent (D)
14/212 BK Virus (BKV)(1st International Standard) Diagnostics Quality Control Reagent (D)
14/224 Influenza virus infectious. A/Switzerland/9715293/2013 Diagnostics Quality Control Reagent (D)
14/226 Influenza Virus Infectious A/South Australia/55/2014 Vaccines Influenza
14/228 Influenza Virus Infectious A/Stockholm/6/2014 Vaccines Influenza
14/230 Influenza Virus Infectious. A/Norway/466/2014 Vaccines Influenza
14/232 Influenza Virus Infectious IVR-175 Vaccines Influenza
14/238 Recombinant Tissue factor Vaccines Pneumococcal vaccines
14/254 Influenza Antigen A/Switzerland/9715293/2013 (NIB88) Vaccines Pneumococcal vaccines
14/256 Human Papillomavirus (HPV) Type 6 DNA (1st International Standard) Vaccines Pneumococcal vaccines
14/258 Human Papillomavirus (HPV) Type 31 DNA (1st International Standard) Vaccines Pneumococcal vaccines
14/260 Human Papillomavirus (HPV) Type 33 DNA (1st International Standard) Vaccines Pneumococcal vaccines
14/262 Human Papillomavirus (HPV) Type 52 DNA (1st International Standard) Vaccines Pneumococcal vaccines
14/264 Human Papillomavirus (HPV) Type 58 DNA (1st International Standard) Vaccines Pneumococcal vaccines
14/274 Influenza Antigen B/Brisbane/9/2014 (Egg Derived) Vaccines Pneumococcal vaccines
14/300 High titre anti-A and anti-B in serum (WHO Reference Reagent). Vaccines Pneumococcal vaccines
14/306 Influenza Virus Infectious NYMC X-243 40180 E13 Vaccines Pneumococcal vaccines
14/308 Influenza Virus Infectious IVR-178 40200 E7 Vaccines Pneumococcal vaccines
14/314 Influenza Virus Infectious NIB-88 Vaccines Pneumococcal vaccines
14/316 Factor IX activated (FIXa) 2nd WHO International Standard Vaccines Pneumococcal vaccines
14/318 Influenza Anti NIBRG-301 (H5) HA Serum (Sheep SH624 and SH625) Vaccines Pneumococcal vaccines
14/322 Influenza Virus Infectious NIB-91 Vaccines Pneumococcal vaccines
15/100 Influenza Antigen B/Utah/9/2014 (Cell Derived) Vaccines Pneumococcal vaccines
15/102 Activated Blood Coagulation Factor X (FXa), Human Vaccines Pneumococcal vaccines
15/104 Influenza Antigen A/South Australia/55/2014 Cell derived Vaccines Influenza
15/106 Ancrod Biotherapeutics Immunogenicity
15/126 Bordetella pertussis toxin (20µg). (2nd International Standard) Vaccines Emerging Viruses (V)
15/130 Clinical Virology Multiplex I: Immunodeficiency panel working reagent for Nucleic Acid Amplification Tests (NAT) Vaccines Influenza
15/134 Influenza Anti-A Switzerland/9715293/2013-Like HA serum Vaccines Pneumococcal vaccines
15/134 Influenza Anti-A Switzerland/9715293/2013-Like HA serum Vaccines Pneumococcal vaccines
15/136 EBOV RNA NP-VP35-GP in-run control Vaccines Pneumococcal vaccines
15/138 EBOV RNA VP40-L in-run control Vaccines Pneumococcal vaccines
15/140 Batroxobin Vaccines Pneumococcal vaccines
15/148 Influenza Virus Infectious NIB-92 Vaccines Pneumococcal vaccines
15/154 Influenza Virus Infectious NIB-93 Vaccines Pneumococcal vaccines
15/158 Influenza Virus Infectious NYMC X-263 Vaccines Pneumococcal vaccines
15/160 Influenza Virus Infectious NIBRG-306 Vaccines Pneumococcal vaccines
15/174 Lupus (oligo-specific) anti-dsDNA antibodies WHO Reference Reagent Vaccines Pneumococcal vaccines
15/180 Blood Coagulation Factor XI, 2016 Plasma Human (2nd International Standard). Blood Coagulation Factor XII, 2017 Plasma, Human (1st International Standard) Vaccines Pneumococcal vaccines
15/182 7th British Working Standard for Blood Coagulation Factors II, IX, X Concentrate Vaccines Pneumococcal vaccines
15/184 Influenza Virus Infectious NYMC X-263B Vaccines Pneumococcal vaccines
15/188 Influenza Virus Infectious NYMC X-263A Vaccines Pneumococcal vaccines
15/194 Influenza Virus Infectious NYMC X-257A Vaccines Pneumococcal vaccines
15/196 Influenza Virus Infectious NYMC X-261 Vaccines Influenza
15/212 Influenza Virus Infectious NYMC BX-53C Vaccines Influenza
15/220 Anti-EBOV plasma, human (WHO Reference Reagent) Vaccines Influenza
15/222 EBOV RNA NP-VP35-GP (WHO Reference Reagent) Vaccines Influenza
15/224 EBOV RNA VP40-L (WHO Reference Reagent) Vaccines Influenza
15/234 Influenza Virus Infectious B/Texas/2/2013  41340 E7 Vaccines Influenza
15/238 Influenza Antigen A/New Caledonia/71/2014 (NYMCX-257A)(Egg derived antigen) Vaccines Influenza
15/240 Erythropoietin Antibody Reference Panel A  (1st WHO Reference Panel) Vaccines Influenza
15/242 Erythropoietin Antibody Reference Panel B (1st WHO Reference Panel) Vaccines Influenza
15/248 Influenza Anti A/Anhui/1/2013 (H7) HA Serum (Sheep SH644 & SH645) Vaccines Influenza
15/250 Influenza Virus Infectious NYMC BX-31 Vaccines Influenza
15/262 1st International Standard for Ebola virus (EBOV) antibodies Sierra Leone Convalescent Plasma Pool Vaccines Influenza
15/266 HHV-6 Virus 1st WHO International Standard Vaccines Influenza
15/270 1st WHO International Reference Reagent  
CD4 T-cells (human)
Vaccines Influenza
15/272 ICS Positive Control-Lymphocytes Vaccines Influenza
15/276 Hepatitis A Virus VL For Nucleic Acid Amplification Techniques (3rd International Standard) Vaccines Influenza
15/294 Influenza virus infectious NYMC BX-59B Vaccines Influenza
15/296 Sabin monovalent Polio vaccine type 2 (1st International Standard) Vaccines Influenza
15/298 Influenza Virus Infectious B/Brisbane/46/2015 Vaccines Influenza
15/300 Influenza Virus Infectious NYMC BX-35  41950 E11 Vaccines Influenza
15/304 Parathyroid hormone 1-34, recombinant, human, 2nd WHO International Standard Vaccines Influenza
16/106 Influenza antigen A/California/7/09 (H1N1) (NYMC-X181) Vaccines Meningococcal Reagents
16/108 Influenza Virus Infectious A/PR/8/34 Vaccines Influenza
16/110 Zika Virus Working Reagent for Nucleic Acid Amplification Testing (NAT) Vaccines Influenza
16/114 Influenza anti - A/California/7/09 HA serum Vaccines Influenza
16/118 Influenza Antigen B/Brisbane/60/2008 (NYMC BX-35) (Egg Derived) Vaccines Influenza
16/120 WHO 1st International Reference Panel for Genomic JAK2 V617F Vaccines Influenza
16/126 Native Vi polysaccharide (S. Typhi) (1st International Standard) Vaccines Influenza
16/138 Anti-Typhoid capsular Vi polysaccharide Ig (Human) 1st WHO International Standard Vaccines Influenza
16/152 Meningococcal serogroup W polysaccharide Vaccines Influenza
16/164 Sabin bivalnet Polio vaccines types 1 and 3 (1st International Standard) Vaccines Influenza
16/170 Infliximab (1st International Standard) Vaccines Influenza
16/182 Influenza Anti-A/Hong Kong/4801/2014-like HA Serum Vaccines Influenza
16/190 Mullerian Inhibiting Substance/Anti-Mullerian Hormone, human, recombinant (WHO reference Reagent) Diagnostics Blood Borne Pathogens
16/192 Influenza Anti - B/Brisbane/60/2008-HA serum Vaccines Influenza
16/194 HIV-1 RNA (4th International Standard) Diagnostics Emerging Viruses (D)
16/196 Sabin monovalent Polio vaccine type 1(1st International Standard) Vaccines Emerging Viruses (V)
16/200 Influenza Virus Infectious NIB-58 Vaccines Emerging Viruses (V)
16/202 OPV reference mOPV 3 Vaccines Influenza
16/204 7th WHO International Standard for Rabies Vaccine Diagnostics Blood Borne Pathogens
16/206 Meningococcal serogroup Y Polysaccharide Diagnostics Quality Control Reagent (D)
16/208 Influenza Virus Infectious NIB-97  42090 E7 Diagnostics Quality Control Reagent (D)
16/210 HIV-1 P24 Antigen (1st international reference panel) Vaccines Influenza
16/236 HIV-2 p26 Antigen (VLP)-HIV-2 A7312 (1st WHO Reference Reagent) Vaccines Influenza
16/238 Influenza Antigen A/Anhui/1/2013 (NIBRG-268) (H7N9) Vaccines Influenza
16/242 Influenza Virus Infectious NIB-98  42110 E7 Vaccines Influenza
16/250 1st International Reference Panel for genomic KRAS codons 12 and 13 mutations Vaccines Influenza
16/268 Influenza Virus Infectious  X-273 Vaccines Influenza
16/270 Influenza Virus Infectious IVR-180 42400 E3/D7/E1 Vaccines Influenza
16/274 Influenza Virus Infectious X-275A  42010 E13 Biotherapeutics Blood Transfusion and Transplantation
16/278 Anti-D Immunglobulin control preparation Diagnostics Emerging Viruses (D)
16/282 Influenza Virus Infectious X-285  42430 ExE1 Vaccines Influenza
16/284 Antiserum to Respiratory Syncytial Virus WHO 1st International Standard Vaccines Influenza
16/286 Influenza Antigen A/Hong Kong/4801/2014  (NYMC X-263B) Vaccines Influenza
16/288 Influenza Virus Infectious X-283A  42420 ExE1 Vaccines Influenza
16/290 Influenza Virus Infectious X-285A  42440 ExE1 Vaccines Influenza
16/292 Influenza Antigen A/Singapore/GP1908/2015  (IVR-180) Vaccines Emerging Viruses (V)
16/296 Human Immunodeficiency Virus type 2 RNA (HIV-2) for Nucleic Acid Amplification Techniques (2nd International Standard) Vaccines Emerging Viruses (V)
16/302 Tetanus Toxoid for use in Flocculation Test (3rd International Standard) Vaccines Influenza
16/320 Zika Antibody Working reagent Vaccines Emerging Viruses (V)
16/324 Human Adenovirus DNA for nucleic acid amplification techniques (1st WHO international Standard). Vaccines Influenza
16/332 Anti-D Immunoglobulin (Replacement IS) Vaccines Influenza
16/344 WHO Anti-EBOV Convalescent Plasma (International Reference Panel) Vaccines Influenza
16/352 Anti-Asian Lineage Zika Virus Antibody (human) (1st international standard) Vaccines Influenza
16/358 Streptokinase (4th WHO International Standard) Vaccines Influenza
16/360 Influenza Virus Infectious NIB-96  41920 E7 Vaccines Influenza
16/362 Influenza Virus Infectious NYMC X-291 42530 E8 Vaccines Influenza
16/364 3rd International Standard for Prekallikrein Activator Biotherapeutics Cytokines and Growth Factors
16/366 Influenza Virus Infectious NYMC X-291A  42540 E8 Vaccines Influenza
16/368 HSV-1 Vaccines Influenza
16/374 Blood Coagulation Factor V, Plasma, Human. (WHO 2nd International Standard) Vaccines Pneumococcal vaccines
16/376 Plasmodium falciparum antigens (1st International Standard) Vaccines Pneumococcal vaccines
16/376 Plasmodium falciparum antigens (1st International Standard) Vaccines Pneumococcal vaccines
1-7 Fimbrae monoclonal antibody, clone 1-7 Vaccines Pneumococcal vaccines
17/100 Prostate Specific Antigen (human)(total: PSA-ACT + free PSA) Vaccines Pneumococcal vaccines
17/102 Prostate Specific Antigen (human) (Free), (2nd WHO International Standard) Vaccines Pneumococcal vaccines
17/106 Influenza Anti-A/Michigan/45/2015-like HA Serum Vaccines Pneumococcal vaccines
17/106 Influenza Anti-A/Michigan/45/2015-like HA Serum Vaccines Pneumococcal vaccines
17/122 HSV-2 Vaccines Pneumococcal vaccines
17/124 Influenza Virus Infectious NYMC BX-63 42790 E10/E1 Vaccines Pneumococcal vaccines
17/126 Influenza Virus Infectious NYMC BX-63A 42780 E10/E1 Vaccines Pneumococcal vaccines
17/132 Influenza Anti NIBRG-306 (H5) HA Serum (sheep SH672 and SH637) Vaccines Pneumococcal vaccines
17/136 Influenza Virus Infectious NIBRG-375 (H7N9) Vaccines Pneumococcal vaccines
17/142 Influenza Antigen A/Duck Vietnam/NCVD-1584/2012 (NIBRG-301) (H5N1) Vaccines Pneumococcal vaccines
17/154 Influenza Antigen A/Michigan/45/2015 (NYMC X-275) Vaccines Pneumococcal vaccines
17/154 Influenza Antigen A/Michigan/45/2015 (NYMC X-275) Diagnostics Immunoglobulins and Immune Sera
17/156 Influenza Virus Infectious CNIC-1701 42910 E9 Vaccines Influenza
17/160 Sabin Inactivated Polio Vaccine (sIPV) (WHO 1st international Standard) Vaccines Influenza
17/162 Influenza Virus Infectious NYMC X-299  42920 E10 Vaccines Influenza
17/164 Influenza Virus Infectious B/Maryland/15/2016 42800 E5 Vaccines Influenza
17/182 Influenza Antigen A/Michigan/45/2015 (NYMC X-275) Vaccines Influenza
17/184 Influenza Virus Infectious NIB-103 42610 E7 Vaccines Influenza
17/190 Influenza Virus Infectious NYMC X-297 42940 E11 Vaccines Influenza
17/194 Influenza Virus Infectious NIB-104 Vaccines Influenza
17/204 1st International Standard for Darbepoetin Vaccines Influenza
17/206 14th British Standard for Coagulation Factor VIII Concentrate, Human. Vaccines Influenza
17/210 Influenza Virus Infectious IVR-186  43310 E8 Vaccines Influenza
17/212 Anti-human leukocyte antigen antibodies (negative serum) Vaccines Anti-Toxins
17/232 Tumor Necrosis Factor alpha (human rDNA derived) Vaccines Clostridium
17/236 Adalimumab (1st WHO International Standard) Vaccines Tetanus
17/238 Anti-human leukocyte antigen antibodies (strong positive plasma) Vaccines Influenza
17/240 5% Immunoglobulin (Negative Control) Vaccines Influenza
17/246 Influenza Antigen A/Singapore/INFIMH-16-0019/2016 (NIB-104) Vaccines Influenza
17/252 Influenza Virus Infectious NYMC BX-69 43220 E13 Vaccines Influenza
17/256 Influenza Virus Infectious NYMC BX-69A Vaccines Influenza
17/256 Influenza Virus Infectious NYMC BX-69A Vaccines Influenza
17/258 Influenza Virus Infectious B/Alabama/2/2017 Vaccines Influenza
17/264 Influenza Virus Infectious A/Michigan/45/2015 43470  E5 Vaccines Influenza
18/100 Influenza Antigen B/Maryland/15/2016 Vaccines Influenza
18/104 Influenza Antigen B/Maryland/15/2016 (NYMC BX-69A) Vaccines Influenza
18/104 Influenza Antigen B/Maryland/15/2016 (NYMC BX-69A) Vaccines Influenza
18/108 Influenza anti-A/Singapore/INFIMH-16-0019/2016- like HA serum Vaccines Influenza
18/110 Influenza Antigen A/Singapore/INFIMH-16-0019/2016 (IVR-186) Vaccines Influenza
18/112 Influenza anti-A/Guangdong-17SF003/2016 (H7) (NIBRG-375) HA Serum Vaccines Influenza
18/116 WHO International Standard Enterovirus 71 (EV71) Inactivated vaccine (Geno Group C4) Vaccines Influenza
18/118 1st International Standard for HCT 15 Cancer Genome Vaccines Influenza
18/120 WHO Reference Reagent Enterovirus 71 (EV71) Inactivated Vaccine (Geno Group C4) Vaccines Influenza
18/130 1st International Standard for MOLT-4 Cancer Genome Vaccines Influenza
18/132D WHO Reference Reagent Lentiviral Vector Copy number by digital PCR 6.75 log 10 LV copies/ampoule Vaccines Meningococcal Reagents
18/132Q WHO Reference Reagent Lentiviral Vector Copy number by quantitative PCR 6.89 log 10 LV copies/ampoule Biotherapeutics Monoclonal Antibodies
18/134 Influenza Virus Infectious NIBRG-301 (H5N1) Vaccines Influenza
18/136 Influenza Virus Infectious NIBRG-14 (H5N1) Vaccines Influenza
18/136 Influenza Virus Infectious NIBRG-14 (H5N1) Vaccines Influenza
18/138 Influenza Virus Infectious NYMC X-307A Vaccines Influenza
18/140 Influenza Virus Infectious NYMC X-307 Vaccines Influenza
18/144 WHO 1st Reference Reagent for Lentiviral Vector Integration Site Analysis Vaccines Influenza
18/146 Pertussis antiserum (human) panel Vaccines Influenza
18/154 Bordetella pertussis, pertactin, PRN Vaccines Influenza
18/156 WHO Reference Reagent Enterovirus 71 (EV71) Inactivated Vaccine (Geno Group B4) Vaccines Influenza
18/160 Influenza Virus Infectious NYMC X-311 Vaccines Influenza
18/164 1st International Standard for ATDB102 Genome Vaccines Influenza
18/166 Influenza Virus Infectious NIB-112 43990 E6 Vaccines Influenza
18/168 Influenza Virus Infectious A/Switzerland/8060/2017 Vaccines Influenza
18/170 Influenza anti-B/Colorado/06/2017-like HA serum Vaccines Influenza
18/174 Influenza Virus Infectious A/Brisbane/1/2018 Biotherapeutics Haemostasis
18/180 2nd International Standard for Diphtheria Antitoxin Equine Vaccines Influenza
18/184 Hepatitis C virus RNA for nucleic acid amplification techniques (6th WHO International Standard) Vaccines Influenza
18/188 Influenza Antigen A / Switzerland / 8060 / 2017 (NIB-112) Vaccines Influenza
18/190 Influenza Antigen A / Brisbane/ 01/2018 (NYMC X-311) Vaccines Influenza
18/192 Influenza Anti-A/Switzerland/8060/2017-like (H3N2) HA Serum Vaccines Influenza
18/194 Influenza Virus Infectious NYMC X-275 (Influenza Reagent) Vaccines Influenza
18/196 Influenza Antigen A/Guangdong/17SF003/2016. NIBRG-375 (H7N9) Vaccines Influenza
18/204 1st International Standard  Anti-citrullinated peptide antibodies (ACPA) Vaccines Influenza
18/206 West Nile Virus - International Standard Diagnostics Blood Borne Pathogens
18/208 WHO Reference Reagent for West Nile Virus  lineage 2 RNA for NAT-based assays Vaccines Influenza
18/210 Bevacizumab (1st WHO International Standard) Vaccines Influenza
18/220 Anti-HPA 15b minimum potency reagent (WHO Reference Reagent) Vaccines Influenza
18/226 Influenza Virus Infectious IVR-190 44250 E12 Diagnostics Emerging Viruses (D)
18/230 Influenza Virus Infectious B/Colorado/06/2017 43460 E7 Diagnostics Emerging Viruses (D)
18/234 Influenza Virus Infectious NIB116-B  44230 E5 Vaccines Influenza
18/236 Influenza Virus Infectious A/Brisbane/02/2018 Diagnostics Quality Control Reagent (D)
18/238 Influenza Antigen A/Brisbane/02/2018 (IVR-190) (H1N1) Diagnostics Quality Control Reagent (D)
18/240 Influenza Virus Infectious NYMC X-327 44280 E17 Diagnostics Quality Control Reagent (D)
18/242 Influenza Virus Infectious A/Kansas/14/2017 43880 E8 Diagnostics Quality Control Reagent (D)
18/244 Human Chorionic Gonadotropin (hCG) (6th International Standard) Diagnostics Quality Control Reagent (D)
18/248 Von Willebrand Factor Concentrate (WHO 3rd International Standard) Diagnostics Quality Control Reagent (D)
19/102 Influenza anti-A/Brisbane/02/2018-like (H1N1) HA Serum (Sheep 698, 699, 700, 701) Vaccines Influenza
19/104 Influenza antigen A/Kansas/14/2017 (NYMC X-327) (H3N2) Vaccines Influenza
19/106 Influenza Virus Infectious IVR-195 44300 E9 Vaccines Influenza
19/108 Trastuzumab (1st WHO international Standard) Vaccines Influenza
19/112 Influenza Virus Infectious NIB-110 Vaccines Meningococcal Reagents
19/114 Anti-Human Neutrophil Antibody 3a WHO Reference Reagent Vaccines Influenza
19/116 1st WHO Plasmodium Vivax Antigen (LDH) Diagnostics Microbiome
19/118 Ferritin (Human, Recombinant) Vaccines Influenza
19/120 Influenza Virus Infectious X-327 A 44310 E18 Vaccines Influenza
19/146 Influenza Virus Infectious CNIC-1903 Vaccines Influenza
19/148 Influenza Virus Infectious CNIC-1902 44320 E10 Vaccines Influenza
19/152 Influenza anti-A/Kansas/14/2017 - Like (H3N2) HA Serum Biotherapeutics Haemostasis
19/154 Influenza Antigen A/Kansas/ 12/2017 (IVR-195) (H3N2) Vaccines Influenza
19/156 Panel of recombinant antibody controls for Cytokine Release Assays Vaccines Influenza
19/160 Influenza Virus Infectious A/California/7/09 44430 E6 Diagnostics Monoclonal Antibodies
19/164 VZV Nucleic acid amplification techniques (1st WHO International Standard) Diagnostics Monoclonal Antibodies
19/166 Insulin-like Growth Factor I, for Immunoassay (2nd WHO international Standard) Diagnostics Monoclonal Antibodies
19/172 Influenza Virus Infectious BVR-11 Diagnostics Monoclonal Antibodies
19/174 Influenza Virus Infectious IVR-197 (H3N2) 44850 E14 Vaccines Influenza
19/176 Influenza Virus Infectious B/Victoria/705/2018 Vaccines Influenza
19/178 1st WHO International Standard for Anti-MERS-CoV Immunoglobulin G (Human) Vaccines Influenza
19/180 Non WHO Reference material Working reagent for Anti-MERS-CoV Antibody Vaccines Influenza
19/188 3rd International Standard Thrombin Biotherapeutics Protein Hormones and Endocrine Products
19/192 Influenza Virus Infectious IVR-202 (H3N2) 44880 E10 Vaccines Influenza
19/194 Influenza Virus Infectious B/Brisbane/35/2018 Vaccines Emerging Viruses (V)
19/198 1st WHO Reference Reagent for anti-malaria (Plasmodium Vivax) human plasma Diagnostics Miscellaneous
19/204 Influenza Antigen A/Newcastle/82/2018 (H3N2) (cell derived) Diagnostics Miscellaneous
19/206 Influenza Virus Infectious X-181  45030 E8 Diagnostics Miscellaneous
19/208 Influenza Antigen B/Victoria/705/2018 (BVR-11) (B Victoria Lineage) Diagnostics Miscellaneous
19/210 Influenza Antigen B/Darwin/7/2019 (B Victoria Lineage) (Cell Derived) Diagnostics Miscellaneous
19/212 Influenza Antigen A/South Australia/34/2019 (IVR-197) (H3N2) Diagnostics Miscellaneous
19/216 Influenza Anti-A/South Australia/34/2019-Like (H3N2) HA Serum (Sheep 712, 713, 714, 715, 716) Vaccines Human Papillomavirus
19/224 Collection of WHO International Standards for Human Papillomavirus (HPV) DNA genotypes HPV16, HPV18, HPV6, HPV11 Vaccines Human Papillomavirus
19/226 Collection of WHO International Standards for Human Papillomavirus (HPV) DNA genotypes HPV31, HPV33, HPV45, HPV52, HPV58 Vaccines Human Papillomavirus
19/228 Influenza Virus Infectious A/South Australia/34/2019 Diagnostics Immunoglobulins and Immune Sera
19/230 Influenza Virus Infectious A/Christchurch/516/2019 H3N2 45010 E4 Diagnostics Quality Control Reagent (D)
19/238 Influenza Antigen B/Washington/02/2019 (B victoria Lineage) Vaccines Influenza
19/240 British Working Standard for Anti-HCV Diagnostics Quality Control Reagent (D)
19/244 Third WHO International Standard for Anti-Rabies Immunoglobulin Diagnostics Tuberculosis (D)
19/246 1st International Standard for human vascular endothelial growth factor-165 (VEGF165) Diagnostics Emerging Viruses (D)
19/256 Influenza Virus Infectious BX-85C 45230 E13 Diagnostics Emerging Viruses (D)
19/258 Influenza Virus Infectious CNIC-1906 44910 E3+3/E9/E1 Vaccines Influenza
19/260 Anti-thyroid peroxidase antibodies (1st WHO International Standard) Vaccines Influenza
19/276 Influenza Virus Infectious NIB-121 (H3N2) 45180 E7/E1/E5 Biotherapeutics Immunoglobulins and Immune Sera
19/276 Influenza Virus Infectious NIB-121 (H3N2) 45180 E7/E1/E5 Diagnostics Quality Control Reagent (D)
19/290 First WHO International Standard for anti-human papillomavirus type 33 serum Vaccines Influenza
19/296 First WHO International Standard for anti-human papillomavirus type 52 serum Vaccines Influenza
19/298 First WHO International Standard for anti-human papillomavirus type 6 serum Vaccines Influenza
19/298 First WHO International Standard for anti-human papillomavirus type 6 serum Diagnostics Quality Control Reagent (D)
19/300 First WHO International Standard for anti-human papillomavirus type 58 serum Diagnostics Quality Control Reagent (D)
19/306 Influenza Antigen A/Victoria/2454/2019 (IVR-207) (H1N1) Vaccines Influenza
19/308 Influenza Antigen B/Singapore/INFTT-16-0610/2016 (B Yamagata lineage) (cell derived) Vaccines Influenza
19/312 Influenza Antigen A/Guangdong-Maonan/SWL1536/2019 (CNIC-1909) (H1N1) Vaccines Influenza
19/314 Influenza Anti-A/ Guangdong-Maonan/SWL 1536/2019-like (H1N1) HA Serum (Sheep 723, 724, 725, 726, 727, 728) Vaccines Influenza
19/316 Influenza anti-A/hongKong/2671/2019-like (H3N2) HA Serum (Sheep 729, 730, 731, 732, 733, 734) Vaccines Influenza
19/318 Influenza anti-B/Washington/02/2019-like (B Victoria lineage) HA Serum (Sheep 737, 738, 739, 740, 741, 742) Vaccines Influenza
19/320 Influenza anti-N2 Neuraminidase Serum (A/South Australia/34/2019) (Sheep 735, 736) Vaccines Influenza
19/322 Influenza anti-B/Phuket/3073/2013-like (B Yamagata Lineage) HA serum Vaccines Influenza
20/102 Influenza Virus Infectious IVR-207 (H1N1) 45370 E4/E6/E1 Vaccines Human Papillomavirus
20/106 Influenza Virus Infectious A/Victoria/2454/2019 (H1N1) 45360 E4/E1 Vaccines Human Papillomavirus
20/108 Influenza Antigen A/HongKong/2671/2019 (NIB-121)(H3N2) Vaccines Human Papillomavirus
20/110 SARS-CoV-2 (NAT) Vaccines Human Papillomavirus
20/112 IVIG + Anti-D (13/148)x2 Negative Control IVIG (12/300) x2 Vaccines Human Papillomavirus
20/132 Influenza Antigen A/HongKong/2671/2019 (IVR-208) (H3N2) Vaccines Influenza
20/134 Influenza Virus Infectious BX-57 45430 E4/E10/E1 Vaccines Influenza
20/138 Working Reagent for SARS-CoV-2 RNA Diagnostics Protein Hormones and Endocrine Products
20/146 First WHO International Standard for SARS-CoV-2 RNA Vaccines Influenza
20/152 First WHO International Standard for Mycobacterium tuberculosis (H37Rv) DNA for NAT-based assays Vaccines Influenza
20/162 NIBSC Anti-SARS-CoV-2 Antibody Diagnostic Calibrant Biotherapeutics Cytokines and Growth Factors
20/164 Influenza Virus Infectious BX-87C (B/VIC) 45460 E3/E10/E1 Vaccines Rabies
20/170 NHS winter Multiplex Working Reagent for Nucleic acid amplification testing (NAT) Diagnostics Blood Borne Pathogens
20/172 1st International Standard for anti-EV68 Serum Vaccines Influenza
20/174 First WHO International Standard for anti-human papillomavirus type 11 serum Vaccines Influenza
20/176 First WHO International Standard for anti-human papillomavirus type 31 serum Vaccines Influenza
20/178 First WHO International Standard for anti-human papillomavirus type 45 serum Diagnostics Human Papillomavirus
20/180 Influenza A (H1N1) Panel Diagnostics Human Papillomavirus
20/182 Influenza A (H3N2) Panel Vaccines Influenza
20/184 Influenza B Panel Vaccines Influenza
20/186 RSV A Panel Vaccines Influenza
20/188 RSV B Panel Vaccines Influenza
20/190 SARS-CoV-2 Panel Vaccines Influenza
20/202 Anti-Lassa Virus Antibodies (1st International Standard) Vaccines Influenza
20/214 Influenza Virus Infectious IVR-216 (H1N1) 45630 E4/D6/E1 Vaccines Parasitology
20/218 Follicle Stimulating Hormone (3rd International Standard) Vaccines Influenza
20/220 Influenza Virus Infectious IVR-217 (H1N1) 45640 E4/D6/E1 Vaccines Influenza
20/234 Influenza Anti-A/Victoria/2570/2019-like (H1N1) HA Serum (Sheep 749, 750, 751, 752, 753, 754) Biotherapeutics Haemostasis
20/236 Influenza Virus Infectious X-349 (H1N1) E3/E9/E1 45720 Vaccines Emerging Viruses (V)
20/238 Influenza Virus Infectious X-349A (H1N1) E3/E11/E1 45730 Vaccines Emerging Viruses (V)
20/250 WHO Reference Reagent Human Monoclonal Antibody for Poliovirus Type 1 Vaccines Influenza
20/252 WHO Reference Reagent Human Monoclonal Antibody for Poliovirus Type 2 Vaccines Influenza
20/254 WHO Reference Reagent Human Monoclonal Antibody for Poliovirus Type 3 Vaccines Influenza
20/256 WHO Reference Reagent Human Monoclonal Antibody for Poliovirus Types 1, 2 and 3 Diagnostics Protein Hormones and Endocrine Products
20/264 Influenza Virus Infectious X-341 + 1P (H3N2) Diagnostics Blood Transfusion and Transplantation
20/264 Influenza Virus Infectious X-341 + 1P (H3N2) Vaccines Influenza
20/292 2nd International Standard for Factor XIII Plasma, Human Biotherapeutics Immunotoxicology
20/294 Influenza Virus Infectious X-347 (H3N2) Vaccines Influenza
20/294 Influenza Virus Infectious X-347 (H3N2) Vaccines Influenza
20/296 Influenza Virus Infectious X-347A (H3N2) Vaccines Influenza
20/296 Influenza Virus Infectious X-347A (H3N2) Vaccines Influenza
20/302 WHO International Reference Reagent for GUT Microbiome analysis by NGS (Gut-Mix RR) Vaccines Influenza
20/310 Influenza Virus Infectious  A/Cambodia/E0826360/2020 (H3N2) Diagnostics Haematinics and Haemoglobin
20/314 2nd WHO International Standard For Meningococcal Capsular Group C Polysaccharide Diagnostics Parasitology
20/318 Influenza Virus Infectious IVR-221 (H3N2) Biotherapeutics Blood Transfusion and Transplantation
20/318 Influenza Virus Infectious IVR-221 (H3N2) Vaccines Influenza
20/322 Influenza Virus Infectious A/Singapore/INFIMH-16-0019/2016 (H3N2) Biotherapeutics Monoclonal Antibodies
20/322 Influenza Virus Infectious A/Singapore/INFIMH-16-0019/2016 (H3N2) Vaccines Influenza
21/100 Influenza Antigen A/Cambodia/e0826360/2020 (IVR-224) (H3N2) Vaccines Influenza
21/110 Working Reagent for Lassa virus RNA Vaccines Influenza
21/112 First WHO International Standard for Lassa virus RNA Diagnostics Quality Control Reagent (D)
21/116 Influenza Antigen A/Tasmania/503/2020 (IVR-221) (H3N2) Diagnostics Quality Control Reagent (D)
21/118 Influenza anti-A/Cambodia/e0826360/ 2020-Like (H3N2) HA Serum Diagnostics Quality Control Reagent (D)
21/120 Influenza Anti-A/Victoria/2570/2019-like (H1N1) HA Serum Vaccines Quality Control Reagent
21/120 Influenza Anti-A/Victoria/2570/2019-like (H1N1) HA Serum Biotherapeutics Haemostasis
21/122 Influenza Virus Infectious X-357A (H3N2) Biotherapeutics Protein Hormones and Endocrine Products
21/122 Influenza Virus Infectious X-357A (H3N2) Vaccines Influenza
21/124 Influenza Virus Infectious B/HongKong/574/2019 (B-Victoria lineage) Vaccines Influenza
21/124 Influenza Virus Infectious B/HongKong/574/2019 (B-Victoria lineage) Vaccines Influenza
21/130 Influenza Virus Infectious SAN-004A (H3N2) Vaccines Influenza
21/130 Influenza Virus Infectious SAN-004A (H3N2) Vaccines Influenza
21/132 Influenza Virus Infectious B/Phuket/3073/2013 (B-Yamagata lineage) Vaccines Influenza
21/136 Influenza Antigen B/Phuket/3073/2013 (B Yamagata lineage) Vaccines Influenza
21/142 9th International Standard Factor VIII Concentrate, Human Diagnostics Blood Transfusion and Transplantation
21/148 Influenza Virus Infectious X-359 (H3N2) Biotherapeutics Monoclonal Antibodies
21/148 Influenza Virus Infectious X-359 (H3N2) Diagnostics Blood Borne Pathogens
21/150 Influenza Virus Infectious X-359A (H3N2) Diagnostics Blood Borne Pathogens
21/150 Influenza Virus Infectious X-359A (H3N2) Biotherapeutics Immunoglobulins and Immune Sera
21/156 Influenza Virus Infectious BX-93A (B-Victoria Lineage) Vaccines Influenza
21/156 Influenza Virus Infectious BX-93A (B-Victoria Lineage) Vaccines Influenza
21/158 Influenza Virus Infectious BX-93B (B-Victoria Lineage) Vaccines Influenza
21/158 Influenza Virus Infectious BX-93B (B-Victoria Lineage) Vaccines Influenza
21/160 Influenza Virus Infectious X-353 (H3N2) Vaccines Influenza
21/160 Influenza Virus Infectious X-353 (H3N2) Diagnostics Blood Borne Pathogens
21/164 Influenza Virus Infectious X-355B (H3N2) Vaccines Diphtheria
21/164 Influenza Virus Infectious X-355B (H3N2) Vaccines Influenza
21/166 Influenza Virus Infectious X-355A-CL (H3N2) Vaccines Influenza
21/166 Influenza Virus Infectious X-355A-CL (H3N2) Vaccines Influenza
21/170 1st International Standard 2022 for the in vitro bioactivities of Cetuximab Vaccines Influenza
21/180 Meningococcal Capsular Group W polysaccharide Diagnostics Genomic Reference Material
21/186 Influenza Virus Infectious A/Tasmania/503/2020 (H3N2) Vaccines Influenza
21/186 Influenza Virus Infectious A/Tasmania/503/2020 (H3N2) Vaccines Entero Virus
21/190 Influenza Virus Infectious X-361A (H3N2) Vaccines Pertussis
21/190 Influenza Virus Infectious X-361A (H3N2) Vaccines Pertussis
21/192 Influenza Virus Infectious BX-97A (B-Victoria Lineage) Biotherapeutics Gene Therapy
21/192 Influenza Virus Infectious BX-97A (B-Victoria Lineage) Vaccines Influenza
21/194 Influenza Virus Infectious A/Hong Kong/2671/2019 Vaccines Influenza
21/194 Influenza Virus Infectious A/Hong Kong/2671/2019 Vaccines Influenza
21/196 Influenza Virus Infectious IVR-224 (H3N2) Vaccines Influenza
21/196 Influenza Virus Infectious IVR-224 (H3N2) Vaccines Influenza
21/204 Influenza Virus Infectious IVR-227 (H3N2) Biotherapeutics Gene Therapy
21/212 Influenza Virus Infectious A/Darwin/6/2021 (H3N2) Biotherapeutics Gene Therapy
21/214 Influenza Virus Infectious A/Darwin/9/2021 (H3N2) Diagnostics Genomic Reference Material
21/216 Influenza Virus Infectious BVR-25 (B-Victoria Lineage) Vaccines Entero Virus
21/216 Influenza Virus Infectious BVR-25 (B-Victoria Lineage) Diagnostics Genomic Reference Material
21/224 Influenza Virus Infectious B/Austria/1359417/2021 (B/Victoria Lineage) Vaccines Entero Virus
21/226 Influenza Virus Infectious NIB-127 (H3N2) Vaccines Influenza
21/228 Influenza Virus Infectious NIB-126 (H3N2) Vaccines Influenza
21/230 1st WHO Reference Reagent Tetanus Antitoxin Equine for use in Flocculation Test Vaccines Influenza
21/230 1st WHO Reference Reagent Tetanus Antitoxin Equine for use in Flocculation Test Vaccines Influenza
21/230 1st WHO Reference Reagent Tetanus Antitoxin Equine for use in Flocculation Test Vaccines Influenza
21/238 Influenza Virus Infectious A/Guangdong-Maonan/SWL/1536/2019 (H1N1) Vaccines Influenza
21/238 Influenza Virus Infectious A/Guangdong-Maonan/SWL/1536/2019 (H1N1) Diagnostics Quality Control Reagent (D)
21/240 Influenza Virus Infectious CNIC-1909 (H1N1) Diagnostics Quality Control Reagent (D)
21/240 Influenza Virus Infectious CNIC-1909 (H1N1) Diagnostics Quality Control Reagent (D)
21/242 Influenza Virus Infectious B/Singapore/WUH4618/2021 (B-Victoria Lineage) Diagnostics Quality Control Reagent (D)
21/242 Influenza Virus Infectious B/Singapore/WUH4618/2021 (B-Victoria Lineage) Diagnostics Quality Control Reagent (D)
21/244 Influenza Virus Infectious B/Michigan/1/2021 (B/Victoria Lineage) Vaccines Influenza
21/246 Influenza Virus Infectious IVR-228 (H3N2) Vaccines Influenza
21/248 Influenza Virus Infectious BVR-27 (B-Victoria Lineage) 46580 Catalogue Influenza
21/248 Influenza Virus Infectious BVR-27 (B-Victoria Lineage) 46580 Vaccines Influenza
21/252 Influenza Virus Infectious IVR-215 (H1N1) Vaccines Influenza
21/266 1st International Standard 2022 Anti-β2GPI IgG 200 IU/Vial Vaccines Influenza
21/268 Anti-pneumococcal serotype 1 monoclonal antibody (clone13-110A Biotherapeutics Immunoglobulins and Immune Sera
21/268 Anti-pneumococcal serotype 1 monoclonal antibody (clone13-110A Biotherapeutics Blood Transfusion and Transplantation
21/270 Anti-pneumococcal serotype 3 monoclonal antibody (clone 15-103FC11 IH5) Biotherapeutics Monoclonal Antibodies
21/272 Anti-pneumococcal serotype 5 monoclonal antibody (clone 1366LC1 IE11) Biotherapeutics Cytokines and Growth Factors
21/274 Anti-pneumococcal serotype 6A / 6C monoclonal antibody (clone 14-107 JG10 IA1/IB1 IIG10) Biotherapeutics Blood Transfusion and Transplantation
21/276 Anti-pneumococcal serotype 7F monoclonal antibody (clone 15-102HG6 ID8) Vaccines Influenza
21/278 Anti-pneumococcal serotype 8 monoclonal antibody (clone 7D3) Biotherapeutics Haemostasis
21/280 Anti-pneumococcal serotype 9N monoclonal antibody (clone 18-125BG4 ID4) Biotherapeutics Protein Hormones and Endocrine Products
21/282 Anti-pneumococcal serotype 9V monoclonal antibody (clone 15-112EG9 IE2) Vaccines Influenza
21/284 Anti-pneumococcal serotype 10A monoclonal antibody (clone 17-117IA3 IIB6) Vaccines Influenza
21/286 Anti-pneumococcal serotype 12F monoclonal antibody (clone 1C1) Vaccines Influenza
21/288 Anti-pneumococcal serotype 14 monoclonal antibody (clone 13-111A) Vaccines Influenza
21/290 Anti-pneumococcal serotype 18C monoclonal antibody (clone 15-104AG5 IIH4) Vaccines Influenza
21/292 Anti-pneumococcal serotype 19A monoclonal antibody (clone 14-105IH8 IE12) Vaccines Influenza
21/294 Anti-pneumococcal serotype 22F monoclonal antibody (clone 17-122 CG1 IC3) Vaccines Polio
21/298 Influenza Virus Infectious A/Michigan/173/2020 (H3N2) Vaccines Influenza
21/306 Influenza Virus Infectious SAN-010 (H3N2) Vaccines Influenza
21/308 2nd International Standard for Interleukin-6 Vaccines Influenza
21/314 Influenza Antigen A/Darwin/6/2021 (IVR-227) (H3N2) Vaccines Influenza
21/316 Influenza Antigen B/Austria/1359417/2021 (BVR-26) (B Victoria Lineage) Vaccines Influenza
21/318 Influenza Antigen A/Darwin/9/2021 (IVR-228) (H3N2) Vaccines Influenza
21/320 Influenza Antigen A/Darwin/9/2021 (SAN-010) (H3N2) Vaccines Influenza
21/322 Influenza Anti-B Neuraminidase Serum (B/Phuket/3073/2013) Vaccines Influenza
21/326 Influenza Anti-B/Austria/1359417/2021 Like (B Victoria Lineage) HA Serum Diagnostics Blood Borne Pathogens
21/330 Influenza Antigen B/Michigan/01/2021 (B/Victoria Lineage) Vaccines Influenza
21/332 1st International Reference Panel for anti-Lassa fever virus antibodies Vaccines Influenza
21/336 Influenza Virus Infectious B/Washington/02/2019 (B-Victoria lineage) Diagnostics Protein Hormones and Endocrine Products
21/338 1st International Standard 2022 Antibodies to SARS-CoV-2 variants of concern Diagnostics Protein Hormones and Endocrine Products
21/340 Second WHO International Standard for anti-SARS-CoV-2 immunoglobulin. Diagnostics Quality Control Reagent (D)
21/346 Influenza Virus Infectious A/Victoria/2570/2019 (H1N1) Diagnostics Quality Control Reagent (D)
21/348 Influenza Virus Infectious B/Utah/9/2014 (B-Yamagata lineage) Diagnostics Quality Control Reagent (D)
21/350 Influenza Virus Infectious BX-59A (B-Yamagata lineage) Diagnostics Quality Control Reagent (D)
21/352 Influenza Virus Infectious B/Brisbane/9/2014 (B-Yamagata) Diagnostics Parasitology
21/366 Influenza Virus Infectious SAN-011 (H1N1) Diagnostics Parasitology
21/368 SARS-Cov-2 Antigen 1st WHO International Standard Biotherapeutics Haemostasis
21/378 Anti-human leukocyte antigen antibodies (weak positive plasma) Diagnostics Blood Borne Pathogens
21/380 Influenza Virus Infectious IVR-208 (H3N2) Vaccines Influenza
21/382 Influenza Virus Infectious X-367A (H3N2) Biotherapeutics Haemostasis
21/382 Influenza Virus Infectious X-367A (H3N2) Vaccines Influenza
21/384 Influenza Virus Infectious X-369A (H3N2) Vaccines Influenza
21/384 Influenza Virus Infectious X-369A (H3N2) Biotherapeutics Haemostasis
21/388 Influenza Virus Infectious B/Guangdong-Zhenjiang/1516/2021 (B-Victoria Lineage) Vaccines Emerging Viruses (V)
21/388 Influenza Virus Infectious B/Guangdong-Zhenjiang/1516/2021 (B-Victoria Lineage) Vaccines Emerging Viruses (V)
22/100 Influenza Antigen A/Victoria/2570/2019 (IVR-215) (H1N1) Biotherapeutics Immunoglobulins and Immune Sera
22/104_BA 1st International Standard 2023 Rift Valley fever virus antibodies for binding  assays (Human Plasma) Diagnostics Blood Transfusion and Transplantation
22/104_NT 1st International Standard 2023 Rift Valley fever virus antibodies for neutralisation assays (Human Plasma) Vaccines Emerging Viruses (V)
22/108 Reference Panel for Lassa virus RNA Vaccines Tetanus
22/118 Influenza Virus Infectious NIB-129 (H3N2) Diagnostics Blood Borne Pathogens
22/120 5th WHO International Standard, Hepatitis B Virus DNA for NAT Vaccines Influenza
22/134 Influenza Virus Infectious BX-107A (B-Victoria Lineage) Vaccines Influenza
22/136 Influenza Virus Infectious A/North Carolina/01/2021 (H1N1)  X-375 Vaccines Influenza
22/136 Influenza Virus Infectious A/North Carolina/01/2021 (H1N1)  X-375 Vaccines Influenza
22/138 Influenza Virus Infectious A/Indiana/02/2020 (H1N1) Vaccines Immunoglobulins and Immune Sera
22/140 Influenza Virus Infectious A/Netherlands 00007/2021 (H3N2) SAN-012 Vaccines Influenza
22/140 Influenza Virus Infectious A/Netherlands 00007/2021 (H3N2) SAN-012 Biotherapeutics Immunoglobulins and Immune Sera
22/142 Influenza Virus Infectious A/Sydney/5/2021 (H1N1) SAN-013 Vaccines Influenza
22/144 Influenza Virus Infectious A/Darwin/22/2021 (H3N2) SAN-014 Vaccines Influenza
22/144 Influenza Virus Infectious A/Darwin/22/2021 (H3N2) SAN-014 Vaccines Influenza
22/146 Influenza Virus Infectious A/Brisbane/02/2018 (H1N1) Diagnostics Genomic Reference Material
22/146 Influenza Virus Infectious A/Brisbane/02/2018 (H1N1) Vaccines Influenza
22/148 Meningococcal Capsular Group Y Polysaccharide Vaccines Influenza
22/154 Influenza Virus Infectious B/Connecticut/01/2021 (B-Victoria Lineage) Diagnostics Blood Borne Pathogens
22/154 Influenza Virus Infectious B/Connecticut/01/2021 (B-Victoria Lineage) Diagnostics Blood Borne Pathogens
22/156 Influenza Virus Infectious A/Norway/16606/2021 (H3N2) NYMC X-373A Vaccines Influenza
22/156 Influenza Virus Infectious A/Norway/16606/2021 (H3N2) NYMC X-373A Vaccines Meningococcal Reagents
22/158 Influenza Virus Infectious A/Netherlands/00007/2021 (H3N2) NYMC X-377 Vaccines Rabies
22/158 Influenza Virus Infectious A/Netherlands/00007/2021 (H3N2) NYMC X-377 Vaccines Polio
22/172 Influenza Virus Infectious A/Lyon/820/2021 (H1N1) NIB-132 Vaccines Influenza
22/174 Influenza Virus Infectious A/Victoria/2570/2019 (H1N1) NYMC X-379 Vaccines Polio
22/178 Influenza Virus Infectious A/Darwin/22/2021 (H3N2) NIB -130 Diagnostics Blood Borne Pathogens
22/178 Influenza Virus Infectious A/Darwin/22/2021 (H3N2) NIB -130 Vaccines Influenza
22/180 Influenza Virus Infectious A/Guizhou/Liuzhite/326/2022 (H3N2) CNIC-2206 Diagnostics Protein Hormones and Endocrine Products
22/180 Influenza Virus Infectious A/Guizhou/Liuzhite/326/2022 (H3N2) CNIC-2206 Vaccines Influenza
22/200 Influenza Virus Infectious A/Sydney/5/2021 (H1N1) Biotherapeutics Monoclonal Antibodies
22/204 Influenza Virus Infectious B/Austria/1359417/2021 (B-Victoria lineage) BVR-26 Vaccines Polio
22/214 Influenza Virus Infectious CBER-48A (A/Sydney/5/2021) (H1N1) Vaccines Meningococcal Reagents
22/220 Influenza Antigen A/Sydney/5/2021 (SAN-013) (H1N1) Vaccines Enteric disease
22/222 Influenza Antigen A/Sydney/175/2022 (IVR-235) (H1N1) Vaccines Enteric disease
22/226 Influenza Anti-A/Darwin/9/2021-Like (H3N2) HA Serum Diagnostics Genomic Reference Material
22/228 Influenza Anti-B/Austria/1359417/2021-like (B Victoria lineage) HA Serum Vaccines Influenza
22/234 Influenza Virus Infectious IVR-235  (A/Sydney/175/2022 (H1N1) Vaccines Influenza
22/234 Influenza Virus Infectious IVR-235  (A/Sydney/175/2022 (H1N1) Diagnostics Emerging Viruses (D)
22/236 Anti-pneumococcal serotype 2 monoclonal antibody (clone 2D1) Vaccines Influenza
22/238 Anti-pneumococcal serotype 4 monoclonal antibody (clone 14-100JA2 IIE7 2H7) Vaccines Influenza
22/240 Anti-pneumococcal serotype 6B monoclonal antibody (clone 14-102GA3 ID10 1B10) Diagnostics Quality Control Reagent (D)
22/242 Anti-pneumococcal serotype 11A monoclonal antibody (clone 8G12) Diagnostics Quality Control Reagent (D)
22/244 Anti-pneumococcal serotype 15B monoclonal antibody (clone 3D3) Diagnostics Quality Control Reagent (D)
22/246 Anti-pneumococcal serotype 17F monoclonal antibody (clone 17-120DG2 IF2) Diagnostics Quality Control Reagent (D)
22/248 Anti-pneumococcal serotype 20 monoclonal antibody (clone 18-121 DF9 IIG8 1B6) Diagnostics Quality Control Reagent (D)
22/250 Anti-pneumococcal serotype 33F monoclonal antibody (clone 3B2) Biotherapeutics Protein Hormones and Endocrine Products
22/254 Anti-pneumococcal serotype 6C monoclonal antibody (clone 1B2) Vaccines Influenza
22/256 Anti-pneumococcal serotype 15A/B monoclonal antibody (clone 3A4) Vaccines Influenza
22/258 Anti-pneumococcal serotype 16F monoclonal antibody (clone 20-121HC4 IA4 IE6) Vaccines Polio
22/260 Anti-pneumococcal serotype 19F monoclonal antibody (clone 8E9- 1B12) Vaccines Influenza
22/262 Anti-pneumococcal serotype 23F monoclonal antibody (clone 15-113HA6 IG2) Diagnostics Blood Borne Pathogens
22/264 Anti-pneumococcal serotype 24F monoclonal antibody (clone 1A6) Biotherapeutics Cell Reference Material
22/266 Anti-pneumococcal serotype 35B monoclonal antibody (clone 3F6) Biotherapeutics Cell Reference Material
22/268 Influenza Virus Infectious SAN-015 (A/Lyon/820/2021) (H1N1) Diagnostics Blood Transfusion and Transplantation
22/270 1st International Reference Panel for antibodies to SARS-CoV-2 variants of concern Vaccines Emerging Viruses (V)
22/272 1st International Reference Panel  for Infliximab anti-drug antibodies Vaccines Influenza
22/274 Influenza Virus Infectious IVR-215 (A/Victoria/2570/2019) (H1N1) Vaccines Influenza
22/276 Anti-pneumococcal serotype 2 monoclonal antibody (clone 1G7) Biotherapeutics Immunogenicity
22/278 Anti-pneumococcal serotype 15B monoclonal antibody (clone 2F4) Biotherapeutics Immunogenicity
22/280 Anti-pneumococcal serotype 23F monoclonal antibody (clone 15-113HA5 IE2 IE2) Vaccines Influenza
22/282 Anti-pneumococcal serotype 24F monoclonal antibody (clone 2F2) Vaccines Influenza
22/284 Anti-pneumococcal serotype CPS monoclonal antibody (clone 14-108BA5 IE10) Diagnostics Ebola Virus
22/286 Anti-pneumococcal serotype 4 monoclonal antibody (clone 14-100JA2 IIE7 2G6) Diagnostics Ebola Virus
22/288 Anti-pneumococcal serotype 5 monoclonal antibody (clone 1366KG3 IA11) Vaccines Emerging Viruses (V)
22/290 Anti-pneumococcal serotype 6B monoclonal antibody (clone 14-102CC2 ID9) Vaccines Influenza
22/292 Anti-pneumococcal serotype 8 monoclonal antibody (clone 6G1) Vaccines Influenza
22/294 Anti-pneumococcal serotype 10A monoclonal antibody (clone 17-117DE8 IIE9) Vaccines Influenza
22/296 Anti-pneumococcal serotype 11A monoclonal antibody (clone 2E2) Vaccines Influenza
22/298 Anti-pneumococcal serotype 12F monoclonal antibody (clone 1C8) Vaccines Influenza
22/300 Anti-pneumococcal serotype 15A-B monoclonal antibody (clone 1B4) Biotherapeutics Haemostasis
22/302 Anti-pneumococcal serotype 16F monoclonal antibody (clone 20-121EC11 IIF10 VE2) Diagnostics Haemostasis (D)
22/304 Anti-pneumococcal serotype 17F monoclonal antibody (clone 17-120AE4 IE3 IG2) Diagnostics Immunoglobulins and Immune Sera
22/306 Anti-pneumococcal serotype 22F monoclonal antibody (clone 17-122 JB11 IB11) Vaccines Influenza
22/308 Anti-pneumococcal serotype 35B monoclonal antibody (clone 3F9) Vaccines Influenza
22/312 Influenza Virus Infectious A/Norway/31694/2022 (H1N1) Vaccines Influenza
22/316 Influenza Virus Infectious A/Victoria/4897/2022 (H1N1) Vaccines Influenza
22/318 Influenza Virus Infectious IVR-238 (A/Victoria/4897/2022 (H1N1) Biotherapeutics Haemostasis
22/320 Influenza Antigen A/Victoria/4897/2022 (IVR-238) (H1N1) Diagnostics Ebola Virus
23/100 Influenza anti-A/Victoria/4897/2022-like (H1N1) HA Serum Diagnostics Ebola Virus
23/106 Methylated Human Serum Albumin (mHSA) Vaccines Influenza
23/112 Influenza Virus Infectious NIB-133 (A/Norway/31694/2022)  (H1N1) Vaccines Influenza
23/114 Influenza Virus Infectious SAN-010 (A/Darwin/09/2021) (H3N2) Diagnostics Quality Control Reagent (D)
23/116 Influenza Virus Infectious SAN-018  (A/Maryland/02/2021) (H3N2) Vaccines Pertussis
23/118 Influenza Virus Infectious SAN-019 (A/Alaska/01/2021) (H3N2) Biotherapeutics Haemostasis
23/120 Influenza Virus Infectious A/Wisconsin/67/2022  (H1N1) Vaccines Influenza
23/122 Influenza Virus Infectious A/West Virginia/30/2022  (H1N1) Biotherapeutics Haemostasis
23/126 Influenza Virus Infectious NIB-134 (A/Catalonia/NSVH161512065/2022  (H1N1) Vaccines Influenza
23/132 Influenza Virus Infectious NYMC BX-117 (B/Zhejiang-Nanhu/1854/2021) (B-Victoria lineage) Diagnostics Quality Control Reagent (D)
23/134 Influenza Virus Infectious NYMC X-387 (A/Maryland/02/2021) (H3N2) Diagnostics Quality Control Reagent (D)
23/136 Influenza Virus Infectious NYMC X-391 (A/Guizhou-Liuhite/326/2021) (H3N2) Diagnostics Quality Control Reagent (D)
23/138 Influenza Virus Infectious NYMC X-391A (A/Guizhou-Liuzhite/326/2021) (H3N2) Diagnostics Quality Control Reagent (D)
23/142 Anti-Meningococcal Human Reference Serum Group B Vaccines Influenza
23/150 Bordetella Pertussis 18323 coating antigen Vaccines Influenza
23/152 Influenza Virus Infectious NYMC X-393 (A/West Virginia/30/2022) (H1N1) Biotherapeutics Haemostasis
23/154 Influenza Virus Infectious NYMC X-393A (A/West Virginia/30/2022) (H1N1) Vaccines Influenza
23/156 Influenza Virus Infectious NYMC BX-115 (B/Zhejiang-Xiacheng/11085/2021 (B/Victoria lineage) Vaccines Influenza
2BADS Anti-Brucella Abortus Serum, Bovine (International Standard) Vaccines Influenza
2CPBETAAT Clostridium Perfringens Beta Antitoxin (2nd International Standard) Diagnostics Blood Transfusion and Transplantation
2CPEPAT Clostridium Perfringens Epsilon Antitoxin (2nd International Standard) Vaccines Influenza
32-1 Filamentous Haemagglutinin monoclonal antibody, clone 32-1 Diagnostics Human Papillomavirus
3-5 Pertactin Monoclonal antibody, Clone 3-5 Diagnostics Human Papillomavirus
520 IPV ELISA MAbs Type 1, 2 and 3  (Type 3; No: 520) Diagnostics Human Papillomavirus
59/015 Gas Gangrene (Cl. Perfringens(Cl. Welchii) Type A), Equine Diagnostics Human Papillomavirus
59/016 Corticotrophin (ACTH), Porcine (3rd International Standard) Diagnostics Human Papillomavirus
59/021 Botulinum  Antitoxin Equine Type A Vaccines Influenza
60/001 Botulinum  Antitoxin Equine Type B Biotherapeutics Haemostasis
60/013 Tetanus Antitoxin, Equine, for Bioassay Vaccines Influenza
62/014 Lysine Vasopressin, Porcine Vaccines Influenza
629E1 Pertussis toxoid monoclonal antibody, clone 629E1 Vaccines Influenza
63/005 Gas Gangrene Antitoxin (Cl. Histolyticum), Equine Vaccines Influenza
64/003 Rheumatoid Arthritis Serum Human Vaccines Influenza
64/014 Gas Gangrene Antitoxin (Cl. Septicum), Equine Diagnostics Blood Transfusion and Transplantation
64/024 Gas Gangrene Antitoxin (Cl. Oedematiens), Equine Biotherapeutics Monoclonal Antibodies
65/093 Anti-Thyroglobulin Serum, Human (WHO Reference reagent) Vaccines Influenza
65/093 Anti-Thyroglobulin Serum, Human (WHO Reference reagent) Vaccines Influenza
65/119 Renin, Porcine Diagnostics Blood Borne Pathogens
65/122 Long-acting Thyroid Stimulator, Human Diagnostics Blood Borne Pathogens
66/138 Gastrin II, Porcine Vaccines Botulinum
66/153 Diphtheria Antitoxin, Equine Biotherapeutics Immunoglobulins and Immune Sera
66/233 Anti-Nuclear Factor Serum (Homogenous) Human Vaccines Meningococcal Reagents
67/037 Immunoglobulin D (IgD) Serum, Human Biotherapeutics Haemostasis
67/099 Immunoglobulins G, A & M Serum Human Vaccines Influenza
67/183 Primary Biliary Cirrhosis Serum, Human Vaccines Influenza
68/340 Anti-Nucleolar Factor Plasma, Human Vaccines Entero Virus
68/356 Renin, Human (International Standard) Vaccines Influenza
69/065 Autoimmune Antibody to Human Spermatazoa Vaccines Influenza
69/194 Glucagon, Porcine (First International Standard) Diagnostics Blood Transfusion and Transplantation
69K/16 Pertactin monoclonal antibody, clone 69K/16 Vaccines Influenza
70/302 Angiotensin II (25µg) Diagnostics Human Papillomavirus
71/281 Anti-Malaria Plasma P Vivax Diagnostics Human Papillomavirus
71/326 Anti-Malaria Plasma Vivax Ng2 Diagnostics Quality Control Reagent (D)
72/092 Anti-malaria Plasma: Plasmodium falciparum (Ghana) Diagnostics Quality Control Reagent (D)
72/096 Anti-Malaria Serum (P.Malariae) Diagnostics Quality Control Reagent (D)
72/341 Anti-Malaria Plasma P Falciparum Diagnostics Quality Control Reagent (D)
72/345 Anti-Malaria Plasma P Falciparum Diagnostics Quality Control Reagent (D)
72/348 Anti-Malaria Plasma P Vivax Diagnostics Quality Control Reagent (D)
73/517 Anti-D (Rho) Antibodies, Human Vaccines Influenza
73/545 Placental Lactogen, Human (International Reference Preparation) Vaccines Meningococcal Reagents
73/554 Cholera Vaccine (Inaba) Vaccines Influenza
73/556 Cholera Vaccine (Ogawa) Vaccines Influenza
73/601 Carcinoembryonic Antigen (CEA), Human (1st International Reference Preparation) Vaccines Influenza
74/520 Serum Proteins (Other than Immunoglobulins) Human Vaccines Influenza
74/581 Ancrod (1st International Reference Preparation) Vaccines Influenza
75/506 Cocksfoot Pollen Extract Vaccines Meningococcal Reagents
75/533 Chorionic Gonadotrophin, Human, for Radioiodination Biotherapeutics Haemostasis
75/535 Chorionic Gonadotrophin beta, Human, for Radioiodination Vaccines Tetanus
75/551 Chorionic Gonadotrophin beta Subunit, Human (International Reference Preparation) Vaccines Entero Virus
75/569 Chorionic Gonadotrophin alpha subunit, Human (International Reference Preparation) Vaccines Influenza
75/595 Blood Coagulation Factor Xa, Bovine Vaccines Influenza
76/508 Chorionic Gonadotrophin alpha Subunit, Human, for Radioiodination Vaccines Influenza
76/515 Mannan (Candida Albicans) Purified Vaccines Polio
76/525 Anti-Birch Pollen Serum, Human Vaccines Polio
76/547 Influenza anti A/Victoria/3/75 Serum(goat) Vaccines Polio
76/575 Oxytocin(4th International Standard) Vaccines Polio
77/503 Anti-Cocksfoot Serum, Human Vaccines Polio
77/512 Lysine Vasopressin(1st International Standard) Vaccines Polio
77/531 Influenza anti A/New Jersey/8/76(H1N1) Serum Vaccines Meningococcal Reagents
77/568 Influenza anti B/Hong Kong/8/73 Serum Diagnostics Blood Borne Pathogens
77/584 Anti-D Pteronyssinus Serum, Human Vaccines Diphtheria
77/600 Mannan (Candida Albicans) Purified Biotherapeutics Haemostasis
77/616 Twelve Grass Pollen Extract Biotherapeutics Cytokines and Growth Factors
77/643 Secretin Vaccines Influenza
77/662 Acarus Siro Extract Vaccines Influenza
77/664 Glycyphagus destructor Extract Vaccines Influenza
78/517 Tyrophagus Putrescentiae Extract Vaccines Influenza
78/543 Kininogenase (Porcine, Pancreatic) (Formerly 1st International Standard) Vaccines Influenza
78/545 Anti-Aspergillus fumigatus Serum, Human Diagnostics Haemostasis (D)
78/554 Luteinizing Hormone, Pituitary, alpha subunit (International Standard) Diagnostics Quality Control Reagent (D)
78/556 Luteinizing Hormone, Pituitary, beta subunit (International standard) Vaccines Influenza
78/560 Influenza Antigen A/Texas/1/77 Vaccines Influenza
78/569 Influenza anti A/Texas/1/77 Serum Vaccines Influenza
78/575 Aspergillus Fumigatus Extract Vaccines Influenza
78/582 Tyrophagus Longior Extract Biotherapeutics Immunoglobulins and Immune Sera
78/628 Bee Venom Diagnostics Protein Hormones and Endocrine Products
79/500 Parathyroid Hormone, HumanRef. Preparation) Vaccines Influenza
79/516 Influenza anti A/Brazil/11/78 Serum (goat) Diagnostics Parasitology
79/552 Influenza  Antigen A/USSR/92/77 Vaccines Influenza
79/558 Influenza Antigen A/USSR/92/77 Vaccines Influenza
79/560 Influenza Antigen A/Brazil/11/78 Biotherapeutics Immunogenicity
79/568 Influenza Antigen B/Hong Kong/8/73 Vaccines Influenza
79/572 Prekallikrein Activator (PKA), Human Vaccines Influenza
80/505 Growth Hormone, Human, Pituitary.  WHO International Standard Vaccines Meningococcal Reagents
80/517 Influenza Antigen A/Bangkok/1/79 Vaccines Influenza
80/519 Influenza Antigen B/Singapore/222/79 Biotherapeutics Haemostasis
80/523 Influenza anti B/Singapore/222/79 Serum Diagnostics Quality Control Reagent (D)
80/525 Influenza anti A/Bangkok/1/79 Serum Vaccines Haemophilus Influenzae type b (Hib)
80/590 Tetracosactide. International Ref. Preparation Biotherapeutics Immunoglobulins and Immune Sera
81/535 Luteinizing Hormone, Human, Pituitary (3rd International Standard) Vaccines Influenza
82/508 Parathyroid Hormone, Human-Type, Synthetic (1-34) fragment Vaccines Influenza
82/512 Parathyroid Hormone, Bovine-Type, Synthetic (1-34) fragment Vaccines Meningococcal Reagents
82/518 Dermatophagoides Pteronyssinus Extract.  WHO International Standard Vaccines Diphtheria
82/520 Timothy Pollen Extract.  WHO International Standard Vaccines Pneumococcal vaccines
82/585 Anti Poliovirus serum types 1,2 and 3 (3rd International Standard) Diagnostics Haemostasis (D)
82/587 Interferon Gamma (Human, Leukocyte derived) Vaccines Influenza
82/632 Parathyroid Hormone, Bovine.  WHO International Standard Vaccines Enteric disease
82/652 Human Serum Vitamin B12, Pernicous anaemia Diagnostics Blood Borne Pathogens
83/501 Beta Thromboglobulin, Purified Human.  WHO International Standard Diagnostics Blood Borne Pathogens
83/505 Platelet Factor 4 Human, Purified.  WHO International Standard Diagnostics Parvovirus
83/511 Insulin, Bovine.  WHO International Standard Vaccines Influenza
83/514 Interferon alpha-1D, (Human rDNA derived)  WHO International Standard Vaccines Influenza
83/515 Insulin, Porcine.  WHO International Standard Vaccines Influenza
83/537 Influenza Antigen A/Philippines/2/82 Biotherapeutics Cytokines and Growth Factors
83/545 Influenza anti  A/Philippine/2/82 Serum Biotherapeutics Cytokines and Growth Factors
83/550 Influenza Antigen A/Brazil/11/78 Vaccines Influenza
83/573 Prolactin, Human (4th WHO International Standard.) Vaccines Influenza
83/575 Follicle Stimulating Hormone, Pituitary.  WHO International Standard Vaccines Influenza
84/514 Proinsulin, Bovine.  International Ref. Preparation Vaccines Influenza
84/522 Birch Pollen Extract.  WHO International Standard Vaccines Influenza
84/528 Proinsulin, Porcine.  International Ref. Reagent Vaccines Influenza
84/538 Influenza Antigen A/Chile/1/83 Vaccines Influenza
84/542 Influenza Antigen B/Norway/1/84 Vaccines Polio
84/581 Short Ragweed Pollen Extract.  WHO International Standard Vaccines Influenza
84/614 Calcitonin, ASU 1-7 Eel Calcitonin Analogue (Elcatonin) WHO International Standard Diagnostics Quality Control Reagent (D)
84/628 Anti-c Serum, Human Vaccines Influenza
84/636 Influenza anti B/USSR/100/83 Serum Vaccines Quality Control Reagent (V)
84/640 Influenza anti A/Chile/1/8 Serum Diagnostics Immunoglobulins and Immune Sera
84/677 Influenza anti A/equine/Miami/63 (H3N8) Serum(goat) Vaccines Influenza
84/685 Dog (Canis Familiaris) Hair Dander Extract.  WHO International Standard Vaccines Influenza
85/506 C-Reactive Protein, Human. WHO International Standard Diagnostics Parasitology
85/516 Influenza anti A/Equine/Kentucky/1/81 HA Serum Diagnostics Blood Transfusion and Transplantation
85/520 Influenza Antigen A/Equine/Kentucky/1/81 Diagnostics Protein Hormones and Endocrine Products
85/522 Thyroid Stimulating Hormone beta subunit Biotherapeutics Monoclonal Antibodies
85/551 Anti-Rye Grass Serum, Human Vaccines Influenza
85/616 Haemoglobin F Lysate, Raised. WHO Reference Reagent Vaccines Influenza
85/669 Atrial Natriuretic Factor, Human. WHO International Standard Biotherapeutics Haemostasis
86/500 Interleukin- 2 (Human, rDNA derived)(2nd International Standard) Biotherapeutics Haemostasis
86/536 Angiotensin I Human Type Synthetic Biotherapeutics Protein Hormones and Endocrine Products
86/538 Angiotensin II (2.5µg) Vaccines Influenza
86/552 Interleukin-1 Beta (Human, rDNA derived) Biotherapeutics Haemostasis
86/576 Influenza Antigen A/Mississippi/1/85 Vaccines Influenza
86/590 Influenza anti A/Mississippi/1/85 Serum Biotherapeutics Protein Hormones and Endocrine Products
86/592 Influenza anti B/Ann Arbor/1/86/HA Serum Vaccines Tuberculosis (V)
86/630 Influenza Antigen B/Ann Arbor/ 1/86 Vaccines Diphtheria
86/632 Interleukin-1 alpha (Human rDNA derived) WHO International Standard Vaccines Influenza
86/678 Interleukin-1 alpha (Human, rDNA derived) Biotherapeutics Haemostasis
86/680 Interleukin-1 beta (Human, rDNA derived) WHO International Standard Diagnostics Parasitology
86/690 Inhibin, Porcine WHO International Standard Diagnostics Blood Transfusion and Transplantation
87/510 Influenza Antigen A/Equine/Miami/63 Diagnostics Blood Transfusion and Transplantation
87/578 Influenza anti A/Leningrad/360/86 Serum Diagnostics Blood Transfusion and Transplantation
87/584 Influenza Antigen A/Leningrad/360/86 Diagnostics Blood Transfusion and Transplantation
87/586 Interferon Gamma (Human, rDNA derived) Vaccines Influenza
87/640 Tumour Necrosis Factor beta (Human, rDNA derived) WHO Reference Reagent Vaccines Influenza
87/654 Anti-Ferritin Monoclonal Antibody (1) Vaccines Influenza
87/662 Anti-Ferritin Monoclonal Antibody (2) Vaccines Influenza
87/714 Influenza Antigen A/Sichuan/2/87 Vaccines Parasitology
87/774 Influenza Antigen B/Victoria/2/87 Biotherapeutics Endotoxin
88/522 Bordetella pertussis (Whole cell vaccine) 3BRP Biotherapeutics Cytokines and Growth Factors
88/532 Tumour Necrosis Factor alpha (Mouse, rDNA derived) Vaccines Polio
88/554 Influenza Antigen B/Beijing/1/87 Vaccines Polio
88/556 Calcitonin, Eel  WHO International Standard Vaccines Polio
88/638 Thyroxine-binding globulin.  WHO International Standard Vaccines Polio
88/646 Granulocyte Macrophage Colony Stimulating Factor (Human, rDNA derived) WHO International Standard Biotherapeutics Blood Transfusion and Transplantation
88/654 Influenza Antigen A/England/427/88 Vaccines Human Papillomavirus
88/656 Interleukin-4 (Human, rDNA derived) WHO International Standard Vaccines Tetanus
88/672 Influenza anti A/Sichuan/2/87 Serum Vaccines Tetanus
88/678 Influenza anti B/Beijing/1/87 Serum Vaccines Diphtheria
88/846 Influenza anti A/England/427/88 Serum Vaccines Diphtheria
89/512 Macrophage Colony Stimulating Factor (CSF-1) (Human rDNA derived) WHO International Standard Vaccines Influenza
89/514 Transforming Growth Factor beta-1 (Human, rDNA derived) Biotherapeutics Haemostasis
89/516 Transforming Growth Factor beta-1 (Bovine) Vaccines Influenza
89/518 Transforming Growth Factor beta-2 (Bovine) Vaccines Influenza
89/520 Interleukin-8 (Human, rDNA derived) WHO International Standard Vaccines Influenza
89/530 Anti-Bordetella pertussis serum (Human) Diagnostics Protein Hormones and Endocrine Products
89/544 Renin, Human, rec DNA Diagnostics Blood Transfusion and Transplantation
89/568 Influenza Antigen A/OMS/5389/88 Vaccines Influenza
89/594 Bordetella pertussis (W28) LPS 2ug Vaccines Influenza
89/596 Bordetella pertussis anti-agglutinogen 1(rabbit) Biotherapeutics Cytokines and Growth Factors
89/598 Bordetella pertussis anti-agglutinogen 2 (rabbit) Vaccines Influenza
89/600 Bordetella pertussis anti-agglutinogen 3 (rabbit) Biotherapeutics Cytokines and Growth Factors
89/620 Calcitonin, Human. WHO International Standard Biotherapeutics Haemostasis
89/666 Haemoglobin A2 Lysate, Raised.  WHO Reference Reagent Diagnostics Blood Transfusion and Transplantation
89/670 Bordetella pertussis (W28) LPS25ug Biotherapeutics Haemostasis
8E1-1H1.2.1 Tetanus toxoid monoclonal antibody, clone 8E1-1H1.2.1 Vaccines Influenza
90/500 Influenza Antigen A/Shanghai/16/89 Biotherapeutics Cytokines and Growth Factors
90/502 Influenza Antigen A/Guizhou/54/89 Vaccines Haemophilus Influenzae type b (Hib)
90/504 Influenza anti A/Guangdong/39/89 Serum Vaccines Influenza
90/520 Bordetella pertussis, filamentous haemagglutinin (FHA) Diagnostics Parasitology
90/530 Interleukin-7 (Human, rDNA derived)  WHO Reference Reagent Diagnostics Parasitology
90/534 Mumps Vaccine (Live)  WHO Reference Reagent Vaccines Influenza
90/586 Interleukin-5 (Human, rDNA derived) WHO Reference Reagent Biotherapeutics Haemostasis
90/636 HIV-1 P24 Antigen  WHO International Standard Vaccines Influenza
90/690 Anti-Varicella-Zoster Antibody Diagnostics Haemostasis (D)
90/696 Transforming Growth Factor beta-2, Human, rec DNA Vaccines Meningococcal Reagents
90/712 Basic Fibroblast Growth Factor (Human, rDNA derived) WHO International Standard Diagnostics Blood Transfusion and Transplantation
90/784 Influenza Virus infectious NIB-26 (H3N2) Vaccines Influenza
91/510 Interleukin-3 (Human, rDNA derived) WHO International Standard Diagnostics Genomic Reference Material
91/530 Epidermal Growth Factor (Human, rDNA derived) WHO International Standard Diagnostics Genomic Reference Material
91/550 Epidermal Growth Factor (1-52) (Human, rDNA derived) WHO Reference Reagent Biotherapeutics Cytokines and Growth Factors
91/554 Insulin-like growth Factor 1 WHO International Standard Vaccines Influenza
91/612 Influenza anti A/Taiwan/1/86 Serum Diagnostics Blood Borne Pathogens
91/624 Recombinant Human Inhibin Vaccines Influenza
91/626 Activin A, Human, Recombinant.  WHO Reference Reagent Vaccines Influenza
91/656 Interleukin-4 (Mouse, rDNA derived) Vaccines Influenza
91/658 Granulocyte Macrophage Colony Stimulating Factor (Mouse rDNA derived) Diagnostics Quality Control Reagent (D)
91/662 Interleukin-3 (Mouse, rDNA derived) Diagnostics Quality Control Reagent (D)
91/670 Influenza Virus infectious NIB-27 (H1N1) Vaccines Influenza
91/678 Interleukin-9 (Human,rDNA derived) WHO Reference Reagent Vaccines Influenza
91/682 Stem Cell Factor (Human rDNA derived) WHO Reference Reagent Vaccines Influenza
91/688 1st International  Reference Reagent Rubella Vaccine (Live) Vaccines Influenza
92/510 Follicle Stimulating Hormone, Human, recombinant. (WHO International Standard) Vaccines Influenza
92/512 Follicle Stimulating Hormone, urofollitropin Human Urinary WHO International Standard Diagnostics Protein Hormones and Endocrine Products
92/518 Macrophage Inflammatory Protein-1 alpha  (Human, rDNA derived) Diagnostics Haemostasis (D)
92/520 Rantes (Human, rDNA derived) Diagnostics Haemostasis (D)
92/530 Influenza Antigen A/Texas/36/91 Biotherapeutics Haemostasis
92/582 Influenza anti B/Yamagata/16/88 Serum Vaccines Influenza
92/628 Influenza Antigen B/Yamagata/16/88 Catalogue Influenza
92/632 Influenza anti A/Beijing/352/89 (H3N2) Serum Vaccines Influenza
92/644 Interleukin-1 Receptor Antagonist (IL-1ra) (Human, rDNA derived) Vaccines Influenza
92/648 Measles Vaccine (Live) 2nd International  Reference Reagent Biotherapeutics Haemostasis
92/654 Plasminogen Activator Inhibitor-1 (PAI-1), plasma Human WHO International Standard Vaccines Influenza
92/658 Papain preparation for use with Anti-D preparation 91/562 Vaccines Tetanus
92/734 Influenza Virus infectious A/Beijing/32/92 (H3N2) Vaccines Influenza
92/738 Influenza Virus infectious A/Shanghai/24/90 Vaccines Influenza
92/788 Interleukin-11 (Human, rDNA derived) WHO Reference Reagent Vaccines Influenza
92/794 Monocyte Chemoattractant Protein-1 (Human,rDNA derived) Diagnostics Protein Hormones and Endocrine Products
93/500 Influenza Antigen A/Beijing/32/92 Vaccines Influenza
93/516 Influenza Antigen A/Shanghai/24/90 Vaccines Influenza
93/518 Influenza anti A/Beijing/32/92  (H3N2) Serum Diagnostics Quality Control Reagent (D)
93/522 Influenza anti A/Shanghai/24/90 (H3N2) Serum Diagnostics Genomic Reference Material
93/556 Nerve Growth Factor (Human, rDNA derived) WHO Reference Reagent Diagnostics Genomic Reference Material
93/560 Insulin-like growth Factor Binding Protein-3 Vaccines Influenza
93/562 Leukaemia Inhibitory Factor (Human, rDNA derived) WHO Reference Reagent Vaccines Influenza
93/564 Oncostatin M (Human, rDNA derived) WHO Reference Reagent Vaccines Influenza
93/566 Interleukin-2 (Mouse, rDNA derived) Vaccines Influenza
93/568 Influenza Virus infectious A/Beijing/359/89 (H3N2) Vaccines Influenza
93/574 Bone morphogenetic Protein-2 (Human, rDNA derived) WHO Reference Reagent Vaccines Influenza
93/668 Interleukin-1 beta (Mouse, rDNA derived) Vaccines Influenza
93/672 Interleukin-1 alpha (Mouse, rDNA derived) Vaccines Influenza
93/692 Influenza Virus infectious B/Panama/45/90 Diagnostics Quality Control Reagent (D)
93/722 Interleukin-10 (Human rDNA derived) WHO Reference Reagent Vaccines Influenza
93/730 Interleukin-6 (Mouse, rDNA derived) Vaccines Influenza
93/740 Interleukin-7 (Mouse, rDNA derived) Biotherapeutics Haemostasis
93/816 Influenza Virus infectious A/Harbin/15/92 (H3N2) Vaccines Influenza
94/500 Influenza Antigen B/Panama/45/90 Vaccines Influenza
94/504 Influenza anti A/Shanghai/9/93 Serum Vaccines Influenza
94/516 Influenza Antigen A/Shangdong/9/93 Biotherapeutics Haemostasis
94/520 Influenza anti B/Panama/45/90 Serum Vaccines Meningococcal Reagents
94/532 Pertussis Vaccine (Whole Cell) WHO International Standard Biotherapeutics Haemostasis
94/622 Interleukin-13 (Human, rDNA derived) WHO Reference Reagent Biotherapeutics Immunoglobulins and Immune Sera
94/674 Thyroid Stimulating Hormone, Human recombinant WHO Reference Reagent Diagnostics Quality Control Reagent (D)
94/684 Ciliary Neurotrophic Factor (Human, rDNA derived) WHO Reference Reagent Vaccines Influenza
94/718 Staphylokinase, rec (STAR) Diagnostics Blood Borne Pathogens
94/728 Platelet-derived Growth Factor-BB (Human, rDNA derived) WHO International Standard Diagnostics Blood Borne Pathogens
94/730 Tissue Plasminogen Activator (tPA) Antigen in Plasma WHO International Standard Vaccines Influenza
94/754 Interferon Omega (Human, rDNA derived) WHO International Standard Vaccines Tuberculosis (V)
94/762 Influenza Virus infectious RESVIR-8 (H3N2) Vaccines Tuberculosis (V)
94/766 Influenza Virus infectious NIB-34 (H3N2) Vaccines Tuberculosis (V)
94/784 Interferon alpha (Human, leukocyte derived)WHO International Standard Biotherapeutics Haemostasis
94/786 Interferon alpha Concensus Sequence (Human rDNA derived) WHO International Standard Diagnostics Blood Transfusion and Transplantation
94/790 MAPREC analysis of Poliovirus  type 3 (Sabin). Synthetic DNA 100% 472-C   WHO International Standard Vaccines Diphtheria
95/510 Influenza Antigen A/Texas/36/91 Diagnostics Haematinics and Haemoglobin
95/516 Influenza Antigen A/Johannesburg/33/94 Vaccines Influenza
95/522 Anti-HBc (Anti-hepatitis B core antigen)  WHO International Standard Diagnostics Immunoglobulins and Immune Sera
95/524 Influenza anti  A/Johannesburg/33/94 Serum Vaccines Influenza
95/528 Folate, Whole Blood Haemolysate  WHO International Standard Vaccines Influenza
95/542 MAPREC analysis of Poliovirus type 3 (Sabin) Synthetic DNA 0.9% 472-C WHO International Standard Vaccines Influenza
95/544 Interleukin-12 (Human, rDNA derived)  WHO Reference Reagent Vaccines Influenza
95/554 Interleukin-15 (Human, rDNA derived) WHO Reference Reagent Vaccines Influenza
95/564 Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Non-Glyc) Vaccines Influenza
95/568 Interferon Alpha n1 (Human lymphoblastoid cell derived) WHO International Standard Vaccines Influenza
95/572 Interferon alpha-1/8 (Human, rDNA derived) WHO International Standard Vaccines Influenza
95/574 Interferon Alpha n3 (Human, leukocyte derived) WHO International Standard Diagnostics Human Papillomavirus
95/580 Interferon alpha-2c (Human, rDNA derived)  WHO International Standard Diagnostics Human Papillomavirus
95/646 Parathyroid Hormone 1-84, human, recombinant (1st International Standard) Vaccines Influenza
95/650 Interferon alpha-2a (Human, rDNA derived)  WHO International Standard Vaccines Influenza
95/656 Interferon alpha 2b (Human rDNA derived)(3rd International Standard) Biotherapeutics Haemostasis
95/668 Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Glyc) Vaccines Influenza
95/674 Anti-Meningococcal Serogroup A mAb Vaccines Pertussis
95/678 Anti-Meningococcal Serogroup C mAb Vaccines Pertussis
96/528 Soluble Tumour Necrosis Factor Receptor Type 1, (Human, rDNA derived) Vaccines Pertussis
96/532 FMS-like tyrosine kinase 3 ligand (Human, rDNA derived) WHO Reference Reagent Vaccines Pertussis
96/534 Brain-derived Neurotrophic Factor (Human, rDNA derived) WHO Reference Reagent Vaccines Influenza
96/538 Insulin-like growth Factor-II (Human rDNA derived) WHO Reference Reagent Vaccines Influenza
96/556 Hepatocyte Growth Factor/Scatter Factor (precursor), (Human rDNA derived) WHO International Standard Vaccines Influenza
96/564 Hepatocyte Growth Factor/Scatter Factor (Human, rDNA derived) WHO Reference Reagent Vaccines Influenza
96/572 MAPREC analysis of Poliovirus type 3 (Sabin) Low virus reference 0.7%472-C WHO Reference Reagent Vaccines Meningococcal Reagents
96/578 MAPREC analysis of Poliovirus type 3 (Sabin) High virus reference 1.1%472-C WHO Reference Reagent Vaccines Meningococcal Reagents
96/602 Luteinizing Hormone,  Human, recombinant  WHO International Standard Biotherapeutics Haemostasis
96/784 Inhibin B, Human  WHO Reference Reagent Vaccines Human Papillomavirus
96/836 Influenza Virus infectious RESVIR-9 (H3N2) Diagnostics Genomic Reference Material
96/850 Influenza Virus infectious NIB-39 (H1N1) Biotherapeutics Haemostasis
97/518 Influenza Antigen A/Johannesburg/82/96 Diagnostics Blood Transfusion and Transplantation
97/538 Anti-Granulocyte Macrophage Colony Stimulating Factor Serum Vaccines Influenza
97/550 Islet Cell Antibodies  WHO Reference Reagent Vaccines Influenza
97/558 Bordetella pertussis anti 69kD serum (sheep) Vaccines Influenza
97/562 Blood Coagulation Factors IXa Concentrate, Human, recombinant(1st I.S.) Vaccines Influenza
97/564 Bordetella pertussis anti FHA serum (sheep) Biotherapeutics Haemostasis
97/572 Bordetella pertussis PT anti serum (sheep) Vaccines Meningococcal Reagents
97/574 Bordetella pertussis anti Fim3 serum (sheep) Vaccines Meningococcal Reagents
97/584 Influenza Antigen A/Equine/Newmarket/2/93 Vaccines Influenza
97/594 Leptin, Human, Recombinant  WHO International Standard Vaccines Influenza
97/596 Influenza Antigen A/Equine/Newmarket/1/93 Diagnostics Genomic Reference Material
97/600 Interleukin-2 Soluble Receptor (human, rDNA derived) Vaccines Influenza
97/610 Influenza anti A/equine/Newmarket/1/93 Serum Vaccines Meningococcal Reagents
97/612 Influenza anti- A/Nanchang/933/95 (H3N2) HA serum Diagnostics Parasitology
97/614 Influenza anti A/Equine/Newmarket/2/93 (H3N8) HA Serum (SH-376) Vaccines Influenza
97/626 Leptin, Mouse, Recombinant  WHO International Standard Vaccines Influenza
97/642 Bordetella pertussis anti serum (mouse) 1RR Biotherapeutics Cytokines and Growth Factors
97/646 Anti-Hepatitis A Immunoglobulin, Human (W1041) WHO International Standard Vaccines Influenza
97/648 Anti-Measles serum (3rd International Standard) Vaccines Meningococcal Reagents
97/692 Influenza Virus infectious IVR-108 (H3N2) Diagnostics Blood Borne Pathogens
97/714 Prolactin, Human, recombinant.  WHO Reference Reagent Vaccines Influenza
97/722 Influenza Virus infectious A/duck/Sing-Q/119/97 (H5N3) Vaccines Influenza
97/748 Influenza Antigen B/Harbin/7/94 Vaccines Influenza
97/756 MAPREC analysis of Poliovirus type 2 (Sabin), low virus reference 0.65%481-G. WHO Reference Reagent Vaccines Meningococcal Reagents
97/758 MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA 0.67%481-G WHO International Standard Diagnostics Haemostasis (D)
97/760 Influenza Antigen A/Beijing/262/95 Vaccines Meningococcal Reagents
98/524 MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA, 100%481-G WHO International Standard Vaccines Meningococcal Reagents
98/540 Anti-D Vaccines Influenza
98/544 Influenza Virus infectious RESVIR-13 (H3N2) Vaccines Influenza
98/572 Diphtheria and Tetanus Antitoxin, Guinea Pig Serum Vaccines Meningococcal Reagents
98/574 Somatropin  WHO International Standard Biotherapeutics Cytokines and Growth Factors
98/580 Prolactin Human, recombinant, glycosylated  WHO Reference Reagent Biotherapeutics Protein Hormones and Endocrine Products
98/582 Prolactin, Human, recombinant, non-glycosylated WHO Reference Reagent Diagnostics Blood Transfusion and Transplantation
98/586 Calcitonin, Salmon.  WHO International Standard Diagnostics Blood Transfusion and Transplantation
98/596 MAPREC analysis of Poliovirus type 2 (Sabin), high virus reference 1.21% 481-G. WHO Reference Reagent Vaccines Meningococcal Reagents
98/600 Influenza Virus infectious NIB-40 (H5N3) Diagnostics Haematinics and Haemoglobin
98/604 Influenza anti B/Harbin/7/94/HA Serum Diagnostics Blood Transfusion and Transplantation
98/610 Influenza Virus infectious ARIV-1 (H5N3) Diagnostics Blood Transfusion and Transplantation
98/666 Influenza anti A/Hong Kong/489/97 (H5N1) Serum (sheep) Biotherapeutics Cytokines and Growth Factors
98/686 Negative Control Guinea Pig Serum (Diphtheria and Tetanus Serology) Biotherapeutics Cytokines and Growth Factors
98/708 Haemiglobincyanide  WHO International Standard Vaccines Meningococcal Reagents
98/714 Tissue Plasminogen Activator, Human, Recombinant WHO International Standard Biotherapeutics Cytokines and Growth Factors
98/718 Neurotrophin 3 Vaccines Meningococcal Reagents
98/762 Influenza Virus infectious Resvir-14 (H3N2) Vaccines Influenza
98/772 Influenza anti A/Beijing/262/95 Serum Vaccines Influenza
98/774 Influenza Antigen B/Shangdong/7/97 Diagnostics Blood Borne Pathogens
98/778 Influenza Virus infectious A/Sichuan/346/98 (H3N2) Diagnostics Haemostasis (D)
99/506 Anti-PT S1 subunit Monoclonal Antibody (1B7) Vaccines Influenza
99/508 Anti-PT S1 subunit Monoclonal Antibody (1D7) Vaccines Influenza
99/510 Anti-PT S1 subunit Monoclonal Antibody (3F11) Vaccines Meningococcal Reagents
99/512 Anti-PT S1 subunit  Monoclonal Antibody (10D6) Vaccines Botulinum
99/514 Anti-PT S1 subunit  Monoclonal Antibody (8G4) Vaccines Meningococcal Reagents
99/516 Anti-PT S1 subunit Monoclonal Antibody (E1E) Vaccines Meningococcal Reagents
99/518 Anti-PT S1 subunit Monoclonal Antibody (E2E) Vaccines Influenza
99/520 Anti-PT S1 subunit Monoclonal Antibody (3F10) Vaccines Tetanus
99/522 Anti-PT S1 subunit  Monoclonal Antibody (11D9) Biotherapeutics Immunoglobulins and Immune Sera
99/524 Anti-PT S1 subunit  Monoclonal Antibody (4D10) Biotherapeutics Immunoglobulins and Immune Sera
99/526 Anti-PT S23 subunit Monoclonal Antibody (11E6) Biotherapeutics Immunoglobulins and Immune Sera
99/528 Anti-PT S23 subunit Monoclonal Antibody (10C9) Diagnostics Blood Borne Pathogens
99/530 Anti-PT S23 subunit Monoclonal Antibody (10B5) Vaccines Japanese Encephalitis
99/532 Anti-PT S23 subunit Monoclonal Antibody (G9A) Vaccines Japanese Encephalitis
99/534 Anti-PT S23 subunit Monoclonal Antibody (3F6) Vaccines Meningococcal Reagents
99/536 Anti-PT S2 subunit Monoclonal Antibody (3A12) Vaccines Meningococcal Reagents
99/538 Anti-PT S2 subunit Monoclonal Antibody (2H3) Vaccines Meningococcal Reagents
99/540 Anti-PT S2 subunit Monoclonal Antibody (9G8) Vaccines Meningococcal Reagents
99/542 Anti-PT S3 subunit Monoclonal Antibody (7E10) Vaccines Influenza
99/544 Anti-PT S3 subunit Monoclonal Antibody (7G11) Vaccines Influenza
99/546 Anti-PT S3 subunit Monoclonal Antibody (4G5) Vaccines Influenza
99/548 Anti-PT S3 subunit Monoclonal Antibody (2E12) Diagnostics Parvovirus
99/550 Anti-PT S3 subunit Monoclonal Antibody (6F8) Diagnostics Parasitology
99/552 Anti-PT S3 subunit Monoclonal Antibody (10B8) Vaccines Influenza
99/554 Anti-PT S4 subunit Monoclonal Antibody (7F2) Vaccines Meningococcal Reagents
99/556 Anti-PT S4 subunit Monoclonal Antibody (6B3) Vaccines Meningococcal Reagents
99/558 Anti-PT S4 subunit Monoclonal Antibody (6G8) Vaccines Botulinum
99/560 Anti-PT S4 subunit Monoclonal Antibody (9F3) Vaccines Botulinum
99/562 Anti-PT S4 subunit Monoclonal Antibody (1H2) Vaccines Botulinum
99/564 Anti-PT S4 subunit Monoclonal Antibody (9C6) Vaccines Botulinum
99/566 Anti-PT S4 subunit Monoclonal Antibody (6D6) Vaccines Influenza
99/568 Anti-PT S5 subunit  Monoclonal Antibody (7E3) Vaccines Influenza
99/570 Anti Filamentous Haemagglutinin Monoclonal Antibody (1C6) Biotherapeutics Cytokines and Growth Factors
99/572 Anti-Filamentous Haemagglutinin Monoclonal Antibody (2E9) Vaccines Meningococcal Reagents
99/574 Anti Filamentous Haemagglutinin Monoclonal Antibody (12G10) Vaccines Pneumococcal vaccines
99/586 Influenza Antigen B/Yamanashi/166/98 Biotherapeutics Cytokines and Growth Factors
99/614 Influenza Antigen A/Sydney/5/97 Biotherapeutics Cytokines and Growth Factors
99/616 Yellow Fever Vaccine. WHO International Standard Biotherapeutics Cytokines and Growth Factors
99/624 Influenza Antigen A/Sydney/5/97 Vaccines Influenza
99/642 Chorionic Gonadotrophin, nicked, human.  WHO Reference Reagent Vaccines Influenza
99/650 Chorionic Gonadotrophin, beta subunit, human. WHO Reference Reagent Vaccines Influenza
99/666 Anti-HPA-5b (Minimum Potency) WHO Reference Reagent Vaccines Influenza
99/674 HIV-2 (antibody) Monitor Sample Vaccines Influenza
99/688 Chorionic Gonadatrophin, intact,  Human. WHO Reference Reagent Vaccines Botulinum
99/692 Chorionic Gonadotrophin, nicked beta subunit, Human WHO Reference Reagent Vaccines Diphtheria
99/706 Anti-Meningococcal human reference serum CDC1992 Vaccines Influenza
99/708 Chorionic Gonadatrophin, beta core fragment, Human WHO Reference Reagent Vaccines Influenza
99/710 Anti-HIV 1 (1 in 5 BWS) Vaccines Influenza
99/710 Anti-HIV 1 (1 in 5 BWS) Vaccines Polio
99/720 Chorionic Gonadotrophin, alpha subunit, Human (purified) Vaccines Polio
99/750 British Working Standard for Anti-HIV 1 Vaccines Polio
99/824 Influenza Virus infectious RESVIR 16 (H3N2) Vaccines Polio
99/828 Influenza Antigen B/Yamanashi/166/98 Vaccines Polio
99/836 Anti-D Minimum Potency Standard for blood grouping reagents WHO International Standard Diagnostics Coronavirus (D)
AFP Alpha-Foetoprotein. WHO International Standard Vaccines Coronavirus (V)
BUSB Botulinum Antitoxin Equine Type B. WHO International Standard Diagnostics Coronavirus (D)
CDS Anti-Canine Distemper Serum. WHO International Standard Vaccines Coronavirus (V)
CHAN Cholera Antitoxin, Goat. WHO International Standard Diagnostics Coronavirus (D)
CHS Anti-Canine Hepatitis Serum Vaccines Coronavirus (V)
COT Clostridium novyi (alpha) Toxoid. WHO Reference Reagent Diagnostics Coronavirus (D)
CWBETATD Clostridium Welchii (Perfringens)(Beta) Toxoid CwBT WHO Reference Reagent Vaccines Coronavirus (V)
CWEPSILTD Clostridium Welchii (Perfringens) (Epsilon) toxoid Diagnostics Coronavirus (D)
DIM9 Diphtheria toxoid monoclonal antibody, clone Dim9 Vaccines Coronavirus (V)
DT05 Diphtheria toxoid monoclonal antibody, clone DT05 Diagnostics Coronavirus (D)
DY Anti-Dysentery (shiga) serum, Equine. WHO International Standard Vaccines Coronavirus (V)
FHADETOX/6 Filamentous Haemagglutinin monoclonal antibody, clone FHADETOX/6 Diagnostics Coronavirus (D)
G10F8C3 Fimbrae monoclonal antibody, clone G10F8C3 Vaccines Coronavirus (V)
HBOHA Lyophilised HBO-HA Antigen for ELISA, Lot 17 Diagnostics Coronavirus (D)
JNIH-11 Bordetella pertussis anti FHA serum (mouse) Vaccines Coronavirus (V)
JNIH-12 Bordetella  pertussis PT( LPF) anti serum, (mouse) Diagnostics Coronavirus (D)
JNIH-3 Acellular Pertussis Vaccine -  1st IS. Vaccines Coronavirus (V)
JNIH-4 Bordetella pertussis filamentous haemagglutinin (FHA) Diagnostics Coronavirus (D)
MEF/001 Primary Mouse Embryo Fibroblasts (p0) Vaccines Coronavirus (V)
MGDS Anti-Mycoplasma gallisepticum Serum. WHO Reference Reagent Diagnostics Coronavirus (D)
NDS Anti-Newcastle Disease Serum. WHO International Standard Vaccines Coronavirus (V)
NVIA Newcastle Disease Vaccine (Inactivated) WHO International Standard Diagnostics Coronavirus (D)
OE Gas Gangrene Antitoxin (Cl. novyi), Equine WHO International Standard Vaccines Coronavirus (V)
PE Gas Gangrene Antitoxin (Cl. Perfringens alpha antitoxin) Equine WHO International Standard Diagnostics Coronavirus (D)
PPDBOV Purified Protein Derivative (PPD) of Mycobacterium bovis Tuberculin (WHO 1st International Standard) Vaccines Coronavirus (V)
PPDT Purified Protein Derivative (PPD) of M. Tuberculosis Tuberculin WHO International Standard Diagnostics Coronavirus (D)
PS21C2.2.1 Pertussis toxoid monoclonal antibody, clone PS21C2.2.1 Vaccines Coronavirus (V)
QCRCMVIgMQC1 QCRCMVIgMQC1  IgM Anti-CMV QC1 Diagnostics Coronavirus (D)
QCRCMVQC1 Anti CMV QC1 QCRCMVQC1 Vaccines Coronavirus (V)
QCREBVIgMQC1 QCREBVIgMQC1 Diagnostics Coronavirus (D)
QCREBVVCAQC1 QCREBVVCAQC1 Vaccines Coronavirus (V)
QCRFERRQC1 Ferritin Quality Control Sample Diagnostics Coronavirus (D)
QCRHAVIgMQC2 QCRHAVIgMQC2 IgM Anti-HAV Quality Control Serum: Sample2 Vaccines Coronavirus (V)
QCRHBCIGMQC1 QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1 Diagnostics Coronavirus (D)
QCRHBeQC1 QCRHBeQC1 Anti-HBe Control Serum: sample1 Vaccines Coronavirus (V)
QCRHBsGQC1 QCRHBsGQC1-HBsAg Quality Control Serum: Sample1 Diagnostics Coronavirus (D)
QCRHBsGQC2 QCRHBsGQC2-Anti HBsAg Quality Control Serum: Sample2 Vaccines Coronavirus (V)
QCRHBsQC1 QCRHBsQC1 Diagnostics Coronavirus (D)
QCRHCVQC1 QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1 Vaccines Coronavirus (V)
QCRHEVIgMQC1 QCRHEVIgMQC1 - IgM Anti-Hepatitis E Quality Control Sample 1 Diagnostics Coronavirus (D)
QCRHEVQC1 QCRHEVQC1 - Anti-Hepatitis E Quality Control Sample 1 Vaccines Coronavirus (V)
QCRHIV1P24QC1 QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1 Diagnostics Coronavirus (D)
QCRHIV1p24QC2 QCRHIV1p24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2 Vaccines Coronavirus (V)
QCRHIV1QC1 QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1 Diagnostics Coronavirus (D)
QCRHIV1QC2 QCRHIV1QC2 - Anti-HIV Quality Control Serum sample 2 Vaccines Coronavirus (V)
QCRHIV1QC3 QCRHIV1QC3-Anti-HIV1:Quality Control Serum:Sample 3 Diagnostics Coronavirus (D)
QCRHIV1QC5 QCRHIV1QC5 - Anti-HIV-1 Quality Control Reagent Sample 5 Vaccines Coronavirus (V)
QCRHIV1RTDQC1 QCRHIV1RTDQC1- Anti-HIV1 Quality Control Serum: Sample 1 for Rapid Test Devices Diagnostics Coronavirus (D)
QCRHIV2QC2 QCRHIV2QC2-Anti HIV2: Quality Control Serum: Sample2 Vaccines Coronavirus (V)
QCRHIV2QC3 QCRHIV2QC3- Anti HIV2: Quality Control Serum: Sample 3 Diagnostics Coronavirus (D)
QCRHIV2QC4 QCRHIV2QC4 - Anti HIV2 Quality Control Serum Sample 4 Vaccines Coronavirus (V)
QCRHSV1QC1 QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1 Diagnostics Coronavirus (D)
QCRHSV2QC1 QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample 1 Vaccines Coronavirus (V)
QCRLYMEIgMQC1 QCRLYMEIgMQC1 IgM Anti-Lyme QC1 Diagnostics Coronavirus (D)
QCRLYMEQC1 QCRLYMEQC1 - Anti-Lyme QC1 Vaccines Coronavirus (V)
QCRMALQC1 QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1 Diagnostics Coronavirus (D)
QCRMEASQC1 QCRMEASQC1 Anti-Measles QC1 Vaccines Coronavirus (V)
QCRMUMPSQC1 QCRMUMPSQC1 - Anti-Mumps Quality Control Reagent Sample 1 Diagnostics Coronavirus (D)
QCRNEGQC1 QCRNEGQC1-Negative Quality Control Serum: Sample1 Vaccines Coronavirus (V)
QCRPARVB19IgMQC1 QCRPARVB19IgMQC1 - IgM Anti-Parvovirus B19 Quality Control Reagent 1 Diagnostics Coronavirus (D)
QCRPARVB19QC1 QCRPARVB19QC1 Anti-Parvovirus B19QC1 Vaccines Coronavirus (V)
QCRRUBIgMQC1 QCRRUBIgMQC1-Anti-Rubella IgM Quality Control Serum: Sample 1 Diagnostics Coronavirus (D)
QCRRUBQC1 QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample 1 Vaccines Coronavirus (V)
QCRRUBQC2 Anti-Rubella QC2 Diagnostics Coronavirus (D)
QCRSARSCOV-2QC1 QCRSARSCoV2QC1 Vaccines Coronavirus (V)
QCRSYPHQC1 QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1 Diagnostics Coronavirus (D)
QCRTHAVQC1 QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1 Vaccines Coronavirus (V)
QCRTHBcQC1 QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1 Diagnostics Coronavirus (D)
QCRTHBcQC2 QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2 Vaccines Coronavirus (V)
QCRTOXOIgMQC1 QCRTOXOIgMQC1 IgM Anti-Toxoplasma QC1 Diagnostics Coronavirus (D)
QCRTOXOQC1 QCRTOXOQC1 - Anti-Toxoplasma gondii Quality Control Reagent Sample 1 Vaccines Coronavirus (V)
QCRVZVQC1 QCRVZVQC1-Anti VZV: Quality Control Serum: Sample 1 Diagnostics Coronavirus (D)
QF Anti-Q Fever Serum, Bovine  WHO International Standard Vaccines Coronavirus (V)
RBT/16 Thromboplastin, Rabbit, Plain 5th International Standard 2016. Diagnostics Coronavirus (D)
RBT/16 Thromboplastin, Rabbit, Plain 5th International Standard 2016. Vaccines Coronavirus (V)
RTF/16 Thromboplastin, Human, Recombinant, Plain 5th International Standard 2016. Diagnostics Coronavirus (D)
RTF/16 Thromboplastin, Human, Recombinant, Plain 5th International Standard 2016. Vaccines Coronavirus (V)
RUBI-1-94 Anti-rubella Immunoglobulin, Human WHO International Standard Diagnostics Coronavirus (D)
SES Swine Erysipelas Serum (anti-N)  WHO Reference Reagent Vaccines Coronavirus (V)
SFS Anti-Swine Fever Serum  WHO International Standard Diagnostics Coronavirus (D)
SMV Smallpox Vaccine  WHO International Standard Vaccines Coronavirus (V)
SPDS-S2 Anti-Salmonella Pullorum Serum (Std. Form S) WHO International Standard Diagnostics Coronavirus (D)
SPDS-V Anti-Salmonella Pullorum Serum (Variant Form V) WHO International Standard Vaccines Coronavirus (V)
SPLS Anti-Staphylococcal P-V Leucocidin serum, Equine WHO Reference Reagent Diagnostics Coronavirus (D)
SS-319/20 FITC CD4 Positive Control Cells Vaccines Coronavirus (V)
SSCLOT5 SSC Secondary Coagulation Standard Lot#5 Diagnostics Coronavirus (D)
STA Staphylococcus Alpha Antitoxin, Equine WHO International Standard Vaccines Coronavirus (V)
STT Diphtheria (Schick) Test Toxin  WHO International Standard Diagnostics Coronavirus (D)
TILI Anti-tick borne encephalitis serum (Louping Ill) WHO International Standard Vaccines Coronavirus (V)
TISA Anti-tick borne encephalitis serum (Sophyn & Absettarov) WHO International Standard Diagnostics Coronavirus (D)
TT010 Tetanus toxoid monoclonal antibody, clone TT010 Vaccines Coronavirus (V)
TYVK Typhoid Vaccine (acetone-inactivated) WHO International Standard Diagnostics Coronavirus (D)
TYVL Typhoid Vaccine (heat-phenol-inactivated) WHO International Standard Vaccines Coronavirus (V)
VI Gas Gangrene Antitoxin (Cl. Septicum), Equine WHO International Standard Vaccines Pertussis
W1004 Anti-C complete blood typing serum,human WHO International Standard Vaccines Pertussis
W1005 Anti-E complete blood typing serum, human WHO International Standard Vaccines Pertussis
W1007 Anti-c Incomplete blood typing serum, human                                      WHO International Standard Vaccines Polio
W1062 Anti smooth muscle(anti actin) autoantibody. WHO Reference Reagent Diagnostics Coronavirus (D)
W1063 Anti nuclear ribonucleoprotein(nRNP) autoantibody WHO Reference Reagent Vaccines Coronavirus (V)
W1064 Anti-Nuclear factor serum,homogenous(66/233) Vaccines Polio
YF Anti-Yellow Fever Serum, monkey  WHO Reference Reagent Vaccines Polio


北京市机械 | 江门市科技官方网站 | 河北人力资源 |